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In numerous pathologies, spontaneous Ca
2+
 release (SCR) emanating from the 
sarcoplasmic reticulum and occurring during the action potential (AP) plateau can drive voltage 
instability that initiates arrhythmias, but the direct interplay between SCRs and arrhythmogeneis 
has not been fully understood in bradycardia and in long QT type 2 (LQT2) models.  
Simultaneous optical measurement of intracellular Ca
2+
 transient (CaiT) and AP were 
performed in Langendorff-perfused rabbit hearts following AV node ablation. Bradycardia 
and/or LQT2 was/were induced and the spatial heterogeneity of intracellular Ca
2+
 handling and 
its link to voltage dispersion were investigated.  
Upon switching from 120 to 50 beats/min, AP duration (APD) increased gradually with 
increasing occurrence of SCRs during the AP plateau (p<0.01, n=7). SCR was a) regionally 
heterogeneous, b) spatially correlated with APD prolongation, c) associated with enhanced 
dispersion of repolarization (DOR), d) reversed by pacing at 120 beats/min and e) suppressed 
with K201 (1µM) or flecainide (5µM), inhibitors of cardiac ryanodine receptors (RyR2) which 
reduced APD (p<0.01, n=5) and DOR (p<0.02, n=5). Western blots of Ca
2+
 channels/transporters 
revealed intrinsic spatial distributions of Cav1.2α and NCX (but not RyR2, and SERCA2a) that 
correlate with the distribution of SCR and underlie the molecular mechanism responsible for 
SCRs.  
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In LQT2, lability of Cai, voltage, and ECG signals increased during paced rhythm, before 
the appearance of early afterdepolarizations (EADs). When EADs appeared, Cai occasionally 
rose before voltage upstrokes at the origins of propagating EADs. Localized, areas of SCRs 
appeared in LQT2 and corresponded to areas of prolonged CaiT and APD. Triggered activity 
appeared after 3-5 min of LQT2 and emanated only at sites with steep membrane potential (Vm) 
gradients (ΔVm gradient percentile: 94.9 ± 3.2%, n=6). Pre- or post-treatment with K201 
suppressed SCRs and decreased DOR, ΔVm and ΔCai. The reduction of ΔVm suppressed 
triggered activity (n=8/9 hearts).  
The results show that bradycardia and LQT2 elicit spatially discordant SCR, which 
is tightly correlated with AP instability. The SCR mediated-enhancement of repolarization 
gradients and AP prolongation can promote arrhythmogenesis. These findings underscore the 
importance of a detailed understanding of Ca
2+
-dependent arrhythmogenic mechanisms for the 
development of rational treatment strategies.  
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1.0 INTRODUCTION 
Coordinated propagation of electrical activity throughout the heart ensures synchronized 
cardiac contraction generating sufficient forces for blood pumping. However, some pathological 
conditions can transform an electrically stable heart into one that unstable, which leads to the 
generation of cardiac arrhythmias. In pathological states, interruption in the spatial organization 
of cardiac wave propagation as a consequence of functional or anatomical conduction barriers 
can initiate cardiac arrhythmias such as ventricular tachycardia (VT) or ventricular fibrillation 
(VF).[1, 2] Experimental studies suggest that dispersion of repolarization (DOR) or spatial 
heterogeneity of cardiac activity increases in numerous pathologies of the heart and has been 
proposed as a fundamental mechanism for the initiation and/or maintenance of arrhythmias when 
the substrate is challenged with premature depolarization (i.e. premature ectopic beats or 
triggered activity).[3-6] Intrinsic regional differences in electrophysiological properties and 
pharmacologic responsiveness of ventricular myocardium have been implicated as a factor of 
DOR. For example, preferential AP prolongation of M-cells in response to antiarrhythmic class 
III drugs has been linked to mechanisms fundamental to markedly enhanced transmural DOR 
under LQT conditions.[7]  However, our understanding of the augmentation of DOR throughout 
a heart under various disease conditions still remains rudimentary.  
In addition to DOR, it is well established that triggered activity as a consequence of 
increases in tissue excitability play an important role in cardiac arrhythmogenesis. Although the 
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emerging role of altered intracellular Ca
2+
 dynamics in the initiation of arrhythmogenic triggered 
activity such as early afterdepolarizations (EADs) or delayed afterdepolarizations (DADs) has 
been extensively reported, the interplay between abnormalities in intracellular Ca
2+
 handling and 
arrhythmogenesis is not fully appreciated. In normal conditions, cardiac contraction and 
relaxation are tightly modulated by membrane potential (Vm) and by Ca
2+
 uptake and release 
which are controlled by proteins on the sarcoplasmic reticulum (SR) membrane (Vm Ca
2+
 
coupling). However, in certain diseases an increase in RyR2 open-probability or interruption in 
Ca
2+
 homeostasis due to an imbalance between Ca
2+
 influx and efflux promotes abnormality in 
Ca
2+
 handling, such as „non‟ voltage gated Ca2+ release. The spontaneous Ca2+ release from 
sarcoplasmic reticulum (SR), in turn, elicit Vm instability via Ca
2+
 dependent sarcolemmal 
transporters (Ca
2+ Vm coupling).[8-11] Specifically, Cai overload in internal Ca
2+
 stores and 
altered kinetics of Cai transients have been documented in ischemia-reperfusion arrhythmias, in 
congenital and drug-induced forms of LQT that produce a characteric polymorphic ventricular 
tachycardia, called Torsade de Pointes (TdP), and in heart failure that leads to reentrant 
arrhythmias.[12-15]  
In addition to the impact of spontaneous SR Ca
2+
 release in the initiation of triggered 
activity, regional variations in intracellular Ca
2+
 [2] handling produce long-short-long-short Cai 
transients that are responsible for spatially discordant Vm instability in heart failure, ischemia, 
long QT syndrome. Recently, our group reported that spatially inhomogeneous Ca
2+
 oscillations 
occur before the onset of „electrical‟ cardiac arrhythmia during drug-induced LQT2.[16] Such 
enhanced spatial heterogeneity of Cai handling in pathologies can be explained by multiple 
factors such as intrinsic ion channel/pump distribution, non-uniform ion channel remodeling, 
local dispersion of sympathetic nerve ganglion, and regional differences of cellular properties.[5, 
 3 
12, 17, 18] Several experimental studies in animal models have shown that the non uniform 
distribution of cellular properties produces regional differences of Cai handling.[11, 12, 19-21] It 
is therefore likely that the spatial heterogeneity of Cai handling could be linked to local 
dispersion of action potential (AP) via Ca
2+
 dependent sarcolemmal transporters.[22] The 
enhanced AP dispersion could serve either as conduction blocks initiating reentrant arrhythmias 
or as re-excitant activity along the abnormal voltage gradient. However, evidence that high 
spatiotemporal heterogeneity of Cai handling is the underlying mechanism of cardiac 
arrhythmogenesis is lacking. 
It is well established that bradycardia increases the likelihood of triggering TdP 
associated with delayed repolarization.[23-25] However, the mechanism through which 
bradycardia facilitates TdP remains unknown. In our previous study, we observed a moderate 
degree of secondary Ca
2+
 elevation with only bradycardia and the bradycardia dependent 
abnormality in Cai  handling was fully reversible by increasing the pacing rate.[16] Despite an 
extensive body of clinical literature suggesting that tachycardia induced alternations of Cai 
handling is responsible for electrical instability,[26, 27] the interplay between bradycardia-
related abnormality in Cai handling and electrical instability has not been investigated.  
Here, we used simultaneous optical measurement of Cai handling and AP dynamics in 
perfused rabbit hearts, and report for the first time that non-voltage gated secondary Ca
2+
 release 
(SCR) in drug induced LQT2 or in bradycardia plays a crucial role in the further prolongation of 
AP. Moreover, the spatial heterogeneity of SCR promotes voltage dispersion across the anterior 
surface of rabbit hearts. Such Ca
2+
-dependent augmentation of voltage dispersion promotes lethal 
cardiac arrhythmias by initiating arrhythmogenic triggered activity along the voltage gradient 
and/or by providing electrophysiological substrates for reentrant activity.  
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2.0 SPECIFIC AIMS 
The goal of the proposed research is to investigate the interplay between Ca
2+
 overload 
and electrical dysfunction in bradycardia and in drug-induced long QT type 2. A complete 
understanding of the mechanism underlying Ca
2+
-dependent electrical dysfunction and 
enhancement of spatial organization of tissue excitability may provide more reliable anti-
arrhythmic therapies. The specific aims of the proposed research are the following:  
Specific Aim #1:  To test the hypothesis that bradycardia can promote an imbalance between 
Ca
2+
 influx and Ca
2+
 efflux, which elicits a secondary Ca
2+
 release (SCR) from internal Ca
2+
 
stores. SCR can produce an arrhythmogenic substrate if a) it prolongs APDs through a reverse 
Cai-Vm coupling during AP plateau and b) SCR is spatially heterogeneous resulting in enhanced 
DOR. This study will provide a mechanistic explanation for bradycardia-dependent arrhythmias, 
which is an important clinical problem.  
Specific Aim #2: To test the hypothesis that secondary Ca
2+
 oscillations (SCaiO) can promote 
LQT2 related arrhythmias by initiating triggered activity and by promoting dispersion of 
repolarization. This includes the impact of SCaO on a) voltage instability, b) the initiation of 
early afterdepolarizations (EADs) or delayed afterdepolarizations (DADs), and c) enhanced 
DOR leading to triggered activity along lines of voltage gradients. This study will demonstrate 
the critical role of spatial heterogeneity of Ca
2+
 abnormalities in the initiation and the 
maintenance of LQT2-related arrhythmias.  
 5 
3.0 BACKGROUND 
During sinus rhythm, the pacemaker action potential initiates cardiac activation 
consisting of electrical waves are highly organized from beat-to-beat and control the mechanical 
contractions associated with each electrical impulse or rhythmic electrical activity. However, 
during ventricular tachycardia (VT) and ventricular fibrillation (VF), the wave propagation is 
interrupted by anatomical or functional conduction blocks.[1, 2] The heart loses its rhythmic 
activity, local muscle contractions become asynchronous with a can-of-worm appearance, and 
the heart fails to pump blood adequately. The occurrence of arrhythmogenic conduction blocks 
can be caused by heterogeneities of slowed conduction or of recovery of excitability.[28, 29] 
More recently, it has been established that disorders in the ion channel kinetics in numerous 
pathologies produce ionic imbalance between transsarcolemmal membranes. The interruption in 
ionic homeostasis can also leads to Ca
2+
 overload in internal SR stores, extracellular 
accumulation of K
+
 concentration, and intracellular elevation of Na
+
 concentration, which have 
been implicated as arrhythmogenic risk factors. In this section, the underlying mechanisms for 
ionic imbalance and the interplay between the ionic imbalance and arrhythmogenesis will be 
introduced.  
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3.1 ELECTROPHYSIOLOGY IN MAMMALIAN HEARTS 
 Rhythmic excitation and contraction (EC) coupling ensures appropriate blood supply 
throughout the body. During sinus rhythm, the action potential (AP) of a pacemaker initiates a 
normal regular cardiac activation, electrical waves are organized, and mechanical contractions 
associated with the electrical activities are rhythmic (see Figure 1).  Such electrical activity, 
called the cardiac AP, is tightly regulated by changes in membrane conductance and ionic 
movement across the sarcolemmal membrane. The ventricular AP consists of five phases, 
number 0 – 4 (see Figure 2).[30] Phase 0 represents membrane depolarization as a consequence 
of rapid activation of voltage gated Na
+
 channels (INa). During phase 1 of AP, partial 
repolarization occurs immediately after the peak of the AP due to the inactivation of Na
+
 
channels combined with activation of transient of outward K
+
 channels (Ito). During phase 2 of 
the AP, which is the plateau phase that is characteristic of a cardiac AP, Ca
2+
 channels (ICa,L) 
open and let Ca
2+
 into the cell while delayed rectifier K
+
 channels open letting K
+
 come out of 
the cell. The simultaneous activity of two currents acting in opposite directions causes this 
plateau phase. Phase 3 represents rapid repolarization of AP as a result of activation of outward 
K
+
 currents. Phase 4 is the final phase of AP, and the membrane potential returns to resting 
potential.  
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Figure 1. Heart and conduction system A) Schematic diagram of heart and conduction 
system.[30] Cardiac rhythms arising in the SA node (SAN) cause atrial contraction (right atria 
(RA) and left atria (LA)). In parallel, electrical activity travels to the AV node (AVN) via 
internodal pathways. After a delay, the sinus rhythm is conducted to the left bundle branch 
(LBB) and the right bundle branch (RBB) then to the purkinje fibers and the endocardium at the 
apex of the heart, then finally to the ventricular myocardium (right ventricle (RV) and left 
ventricle (LV)). B) Examples of normal ECG (top) and long QT ECG (bottom). QT prolongation 
appears in long QT ECG.  
 
Figure 2. Cardiac action potential and ion currents [30] Inward INa causes a rapid upstroke of 
cardiac AP (Phase 0). Ito mediates phase 1 notch. ICaLCa,L and delayed rectifying outward K
+
 
currents (IKr, and IKs) sustain AP plateau (Phase 2). Outward IKr and IKs mediates rapid AP 
repolarization (Phase 3) and IK1 helps recovery of resting membrane potential (Phase 4).  
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3.1.1 K
+
 dynamics 
K
+
 channels are ubiquitous membrane proteins that contribute to cardiac electrical 
activity by regulating membrane resting potential and AP repolarization. The resting membrane 
potential is determined by the K
+
 gradient between the extracellular and cytosolic space. Since 
activation and the recovery from inactivation of voltage gated INa and ICa,L currents are highly 
dependent on the membrane potential, K
+
 dynamics is a dominant factor in regulating tissue 
excitability.[31] Alternation of extracellular K
+
 concentration ([K
+
]ex) is also recognized as a 
major factor of automaticity of both pacemaker cells and working myocytes.[32, 33] For instance, 
a moderate increase in [K
+
]ex causes the elevation of resting membrane potential in pacemaker 
cells.  
Furthermore, various K
+
 channels contribute to action potential (AP) dynamics. For 
example, the delayed rectifier current (IKr and IKs) elicit AP repolarization. Transient outward 
current (Ito) contributes to the repolarization of phase 1 of AP, and inward rectifier current (IK1) 
helps recovery to the resting membrane potential by mediating a small hyperpolarizing K
+
 
current.[30] 
3.1.2 Interventions of K
+
 dynamics and cardiac arrhythmias 
Experimental studies have shown that elevations in [K
+
]ex, known as hyperkalemia, can 
be caused by oxygen depletion due to coronary occlusion and are associated with 
arrhythmogenesis.[34, 35] For example, ischemia-induced hyperkalemia predisposes the heart to 
the development of lethal reentrant ventricular arrhythmias by causing sustained membrane 
depolarization that leads to slowing conduction and altered refractoriness.[36] It is also widely 
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recognized that potassium K
+
 deficiency can be associated with a variety of cardiac arrhythmias. 
For example, it is well known that reduced K
+
 concentration in blood serum, known as 
hypokalemia, decreases the delayed rectifier current (IKr), and results in cardiac arrhythmias by 
causing AP prolongation.[37] 
In addition, due to the primary roles of K
+
 currents in AP repolarization, abnormalities in 
K
+
 currents during APs often induce life-threatening tachyarrhythmias. Typically, inhibition of 
IKr is thought to result in arrhythmogenic AP prolongation and promote the occurrence of LQT2-
related arrhythmias such as TdP.[38] In addition, abnormal AP shortening reduces refractory 
periods and provides a favorable substrate for reentrant arrhythmias.[39]  
3.1.3 Extracellular K
+
 accumulation (EKA) and its role in arrhythmogenesis 
Voltage-clamp and K
+
 selective electrodes have shown that K
+
 accumulation occurs in T-
tubules and narrow clefts between cells indicating that K+ concentration ([K
+
]) in these narrow 
spaces is not in diffusional equilibrium with the external K
+
 concentration (~ 4.7 mM).[40, 41] In 
normal physiology, K
+
 efflux from the cell is pumped back via Na/-K pump - and the local 
external [K
+
] recovers on a beat-to-beat basis.[42] However, at high heart rates or during 
ischemia, a local EKA rise of 2-5 mM can cause a small but significant depolarization which 
alters excitability and can change the shape and time course of subsequent APs.[43, 44] Such a 
spatial and dynamic variation of EKAs can cause variations in tissue excitability, produce local 
conduction blocks, and has been shown to be sites of premature ectopic beats.[45, 46] High 
EKAs can occur during stress in physiological conditions such as high heart rates where EKAs 
may not fully recover from beat to beat resulting in [K
+
]ex elevation or from local coronary 
occlusion and the ensuing ischemia and may worsen during VT and VF. [47, 48] The spatial 
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variation of EKAs induces inhomogeneous slowing of conduction velocity, which may alternate 
dynamically to cause blocks of wave propagation that can lead to triggered out-of-phase ectopic 
beats.[43, 44, 47, 48] The dispersion of EKAs can lead to inhomogeneous tissue excitability, and 
alternans, and the spatial excitability variation plays an important role in initiating and 
maintaining cardiac arrhythmias.  
3.1.4 Na
+
 dynamics  
The voltage-gated cardiac Na
+
 channel is responsible for the generation of the rapid 
membrane depolarization during cardiac AP and thereby plays a crucial role in the excitability of 
cardiomyocytes.[49] In addition, since the AP upstroke velocity also determines impulse 
conduction velocity in cardiac tissue, this channel also contributes to the conduction of electrical 
activity through the heart by facilitating intercellular communication via gap junctions.[50] It is 
also well known that Na
+
 dependent transporters such as Na-K pump, Na/Ca exchanger (NCX), 
and Na/H exchanger (NHE) [51], play a crucial role in regulation of ionic homeostasis.[52]  
Due to the crucial role of Na
+
 channels in tissue excitability and conductivity, its 
abnormal activity has been implicated as a major risk factor in various arrhythmogenic 
models.[53-55] Inherited mutations in SCN5A that encode the α subunits of Na+ channels result 
in several different types of arrhythmias. As a consequence, the gain-of-function mutations in the 
gene increases Na
+
 influx during APs, then prolongs cardiac AP, and eventually promotes long-
QT type 3 related arrhythmias.[56] Alternatively, deletion or loss-of-function mutations of the 
gene have been linked to multiple types of arrhythmias including bradycardia, atrioventricular  
(AV) conduction delay, and Brugada syndrome.[57-60] Also, pharmacological blocks of cardiac 
Na
+
 channels result in slowing conduction and produce marked sudden cardiac death.[61] 
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In healthy cardiac myocytes, intracellular Na
+
 concentration ( [Na
+
]i) is tightly regulated 
by Na
+
 dependent transporters such as NCX, Na-K ATPase, and NHE. Under some pathological 
conditions, those regulatory processes can be interrupted and result in [Na
+
]i accumulation.[17, 
62] The elevation of [Na
+
]i reverses NCX and promotes sarcoplasmic reticulum (SR) Ca
2+
 
overload. Such a cellular Ca
2+
 overload, secondary to Na
+
 overload, can increase the propensity 
of non-voltage gated SR Ca
2+ 
release, which is arrhythmogenic.[63] 
3.1.5 Ca
2+
 dynamics 
Ca
2+
 is primarily responsible for cardiac contraction. Cardiac AP initiated by  Na
+ 
entry 
across the sarcolemma activates voltage-gated L-type Ca
2+
 channels, and Ca
2+
 entry which 
triggers SR Ca
2+
 release by a phenomenon known as Ca
2+
 induced Ca
2+
 release (CICR).[64, 65] 
Transient increases in Cai concentration force Ca
2+
 ions to bind to the myofilament protein 
troponin C and eventually initiate cardiac contraction (see Figure 3). In addition to its role in 
cardiac contraction, Ca
2+
 regulates ionic influx and efflux via NCX or calcium-gated activated 
potassium K
+
 channels (see Figure 3).[66, 67] In Ca
2+
 mediated signaling pathways, Ca
2+
 
regulates many different cellular functions.[68, 69] 
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Figure 3. Schematic diagram of calcium Ca
2+
 induced calcium Ca
2+
 release [64] Ca
2+
 Influx 
through voltage gated L- type   Ca
2+
 channel induces SR Ca
2+ 
release via RyR2. Released Ca
2+
 
binds to myofilamenents and initiates cardiac contraction.   
3.1.6 Abnormality in Cai handling and its role in cardiac arrhythmogenesis 
Cardiac contraction is initiated by an increase in intracellular Ca
2+ 
concentration ([Ca
2+
]i) 
as a result of SR Ca
2+
 release via RyR2 in response to Ca
2+
 entry through the L-type Ca
2+
 
channels, known as the phenomenon of CICR.  
In general, abnormal Cai handling such as SCR has been implicated as a fundamental mechanism 
that underlies the induction of arrhythmias in numerous cardiac diseases.[11, 16, 70-72] The 
SCR has been documented in ischemia-reperfusion arrhythmias, congenital and drug-induced 
forms of long QT that produce polymorphic VT, and in heart failure that leads to reentrant 
arrhythmias. [8, 14, 70, 73] 
In experimental settings, diverse hypotheses for the mechanism underlying SCR have been 
proposed. For example, in the condition of delayed repolarization or of inhibition of Na-K 
ATPase by cardiac glycosides, the SR can become overloaded with Ca
2+
. The SR Ca
2+
 overload 
makes SR more prone to SCR. Such SCR from the SR propagates as a Ca
2+
 wave by CICR.[63] 
Some of the Ca
2+
 released during a wave is removed from the cell by the electrogenic NCX 
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resulting in a net depolarization. This is the cellular mechanism underlying delayed 
afterdepolarizations (DADs), which often precede certain types of fatal cardiac arrhythmias.[74, 
75] More recently it has been proposed that arrhythmogenic SCR can also occur due to the 
increase in RyR2 open probability as a consequence of increase in CSQ or RyR2 sensitivity to 
luminal free Ca
2+
 due to CPVT mutations.[76, 77] Redox modification of RyR2 by oxygen free 
radicals increases RyR2 leakage and facilitates SCR, which triggers ischemia-reperfusion 
arrhythmias.[71, 78] Protein kinase A (PKA) mediated hyperphosphorylation of RyR2 has been 
reported in heart failure.[79, 80] If such a SCR occurs before the complete termination of AP 
repolarization, the SCR elevates cytosolic Ca
2+ 
level and results in arrhythmogenic triggered 
activity such as EADs by promoting Ca
2+
 sensitive inward currents (INCX).[81, 82]  
3.1.7 Regional variation of Cai handling and its link to arrhythmogeneis 
Some experimental studies in intact rabbit models have reported that gradients of Cai 
transients exist on the basal/apical and endocardial/epicardial axes.[19, 20] For example, the 
endocardium exhibits a slower uptake of intracellular Ca
2+
 compared with the epicardium, likely 
as a consequence of the transmural difference of SERCA2a expression. Recently, Sims et al. 
reported that a higher density of CaV1.2a (L-type Ca
2+
 channel gene) is expressed more at the 
base than the apex of the LV, and EADs in LQT2 are more pronounced in the base than the apex 
of the LV of adult female rabbits.[12] Furthermore, a clinical study has shown that the duration 
of cardiac contraction, which was measured by an ultrasound technique in LQT patients, is 
transmurally heterogeneous.[83] 
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3.2 LONG QT TYPE SYNDROME (LQT2)) 
Long QT syndrome (LQTS) is an abnormal condition in which prolongation of the APD 
can lead to sudden cardiac death by inducing polymorphic tachyarrhythmias. Among LQTS, 
LQT2 is the second most common gene location that is affected in long QT syndrome, making 
up about 25% of all cases. Typically, two different forms of LQT type 2 (LQT2), congenital 
LQT2 and acquired LQT2, have been characterized.[84-87] First, the congenital form represents 
a “pure global repolarization disease”. The congenital form of LQT2 is caused by mutation of 
human ether-a-go-go gene (HERG), also known as KCNH2 which encodes the alpha subunit of 
K
+
 channel responsible for IKr.  The loss of function of IKr delays repolarization of AP and 
consequently results in APD prolongation. Second, the acquired LQTS is of critical importance 
because of its prevalence in the clinical setting. The high binding affinity of the HERG channel 
to a wide range of drugs due to its very susceptible amino acid residues has been a serious public 
health problem because cardiac and nor-cardiac drugs inadvertently block the IKr channel from 
conducting currents, and impairs repolarization of AP.[88] In addition, several factors (e.g., 
medications, electrolyte abnormalities, and heart failure) delay ventricular repolarization and 
may lead to lethal arrhythmias. 
 
3.2.1 EADs and DADs in LQT2  
 
Under LQT2 conditions, the EADs are classically attributed to an inward current carried 
by L-type Ca
2+
 channels.[89] In other words, it has been proposed that under conditions 
conducive to EADs, the sarcolemma spends a longer period of time in the voltage range where 
both the activation and inactivation gates of L-type Ca
2+
 channel are partially open. The resulting 
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enhancement of ICa,L during phase 3 of ventricular action potential may be sufficient to cause an 
EAD. Alternatively, secondary Ca
2+
 release from an overloaded SR to the cytoplasm could cause 
EADs by augmentation of the electrogenic INCX, a mechanism previously shown to be 
responsible for the generation of delayed afterdepolarizations (DADs).[11, 14, 81] 
3.2.2 Dispersion of repolarization (DOR) 
Conventionally, regional differences in outward K
+
 currents have been attributed to 
the DOR.[90-93] In mammalian hearts, K
+
 channels are spatially heterogeneous across the wall 
of the ventricles (epicardium to endocardium) as well along the wall (base to apex). 
Experimental studies suggest such intrinsic DOR increases in numerous pathologic conditions 
(bradycardia, LQT, ischemia-reperfusion, and heart failure) and has been proposed as a 
mechanism fundamental to the initiation and maintenance of arrhythmias.[94-96] Typically, 
preferential action potential (AP) prolongation of M cells under conditions with reduced IKr has 
been proposed as a major underlying mechanism responsible for enhanced transmural DOR in 
LQT2.[7, 97] Alternatively, functional differences in levels of IKr along the surface of a heart that 
can be inhibited by class III anti-arrhythmic agents has been linked to a mechanism underlying 
epicardial DOR in cryoablated LQT2 models.[11]. In LQT2 models, once triggered activity 
occurs, enhanced DOR plays a crucial role in maintaining LQT2 related arrhythmias by 
providing a favorable substrate for unidirectional conduction blocks leading to reentrant 
arrhythmias.[98]  
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3.2.3 LQT2 related reentrant arrhythmia 
If propagation of cardiac electrical activity is disrupted by anatomical or functional 
conduction blocks,[1, 2] the heart loses its rhythmic activity, cardiac muscle contraction is 
locally dissociated, and the heart fails to pump an adequate amount of blood. The 
arrhythmogenic conduction blocks can be caused by heterogeneous slowing of conduction and/or 
a spatial dispersion of recovery of excitability.[28, 29] In LQT2 conditions, reentrant activity 
occurs when the wave propagation of premature ectopic beats is interrupted upon encountering a 
region of refractory tissue but conducts though excitable areas (unidirectional propagation) 
leading to functional reentry, which results in LQT2 related polymorphic tachyarrhythmias, 
known as TdP (see Figure 4).[98, 99] An alternative mechanism has been proposed in optical 
mapping studies of Langendorff perfused rabbit hearts treated with the IKr blocker, E4031. In 
these studies APD prolongation was associated with Cai oscillations then became increasingly 
more severe and elicited EADs where Cai preceded the upstroke of EADs. EADs occurred at 2 to 
4 sites in the heart and were of sufficient magnitude to propagate and collide with wavefronts 
emanating from other EADs. TdP was then caused by EADs firing out-of-phase from different 
sites causing the sinusoidal pattern seen on EKG recordings. Thus, optical images of TdP agreed 
with the hypothesis of Desertenne that was proposed in 1966.  
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Figure 4. Typical examples of human ECGs during TdP (top) and ventricular fibrillation 
(bottom) in LQT conditions [30] QTc prolongation precedes the occurrence of TdP.  
 
 
Figure 5. ECG recording in lead D2 during T-wave alternans in a LQT patient [100] T-
waves alter during 4 consecutive beats (beats I, II, III, IV). 
3.2.4 T-wave lability (TWLI) 
Electrocardiography (ECG) has been widely used in both clinical and experimental 
settings for the measurement of electrical activity of a heart. Typically, unusual morphology in 
ECG represents abnormalities in cardiac rhythms. Abnormal ECG characteristics such as QTc 
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prolongation and unusual morphology of T wave (alternans and variation) have been reported in 
LQT patients (see Figure 5).[100-103]Also, in a chronic heart failure model, inter-lead QT 
dispersion is markedly enhanced and beat to beat variation in repolarization morphology in ECG, 
known as TWLI, has been thought to be a marker of pro-arrhythmic conditions.[104] 
3.2.5 Rate and time dependent APD adaptation and its relevance to LQT2 arrhythmias 
APD adaptation, also known as QT accommodation, allows a heart to maintain an 
acceptable ratio between the period of ventricular filling and ventricular contraction.[105] Most 
studies attribute APD adaptation to changes in cytosolic Ca
2+
 [2] which in turn alters the kinetics 
of Ca
2+
-dependent inactivation of L-type Ca
2+
 channels[64, 65, 106]  but others have implicated 
the rate-dependence of INCX [107] and of the late Na
+
 current, INa,L.[108] Besides ion channel 
kinetics, changes in ionic concentrations in the cytoplasm (intracellular Na
+
 and Cai) or 
extracellular K
+
 contribute to APD adaptation.[109, 110] Mathematical simulations of slow heart 
rate (HR) indicated that the long diastolic intervals result in a complete deactivation of the slow 
component of the delayed rectifying K
+ 
current (IKs) and complete recovery from inactivation of 
L-type Ca
2+
currents (ICa,L) which could theoretically explain APD adaptation in 
bradycardia.[111-113] Long-term memory, unlike short term memory, is related to pacing 
induced ion channel remodeling (such as reduction in ICa,L and Ito) taking several days to reach to 
a new steady-state, and plays an important role in long term APD accommodation. [114]The rate 
and time dependent APD-accommodation occurring within minutes is thought to be spatially 
heterogeneous due to the intrinsic heterogeneity of ion channel distribution, specifically IKs 
distribution.[113, 115] Such a rate dependent APD prolongation is associated with markedly 
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enhanced dispersion of APD and explains why LQT2 related arrhythmia is more pronounced 
during bradycardia.  
3.3 STEEP VOLTAGE GRADIENT AND ARRHYTHMOGENESIS 
Experimental studies have suggested that steep voltage gradients can be produced by 
premature stimuli and/or myocardial infarction.[116, 117] Abnormal voltage gradients as a result 
of heterogeneous ion accumulation and cellular uncoupling across the ischemic border zone can 
account for the driving force for the diastolic „injury current‟ to the normal side of the ischemic 
border. Such small injury currents can cause a slight depolarization of the normal tissue and may 
facilitate triggered activity.[116]  
3.4 MEASUREMENTS OF CARDIAC AP AND INTRACELLULAR Ca
2+
 DYNAMICS 
In the past, although glass pipette microelectrodes have contributed as great deal toward 
understanding of the ionic basis of the cardiac AP, the application of single cell impalements is 
not precise for studies requiring simultaneous recording of APs from multiple sites. The 
spatiotemporal pattern of wave propagation of cardiac electrical activity is an important marker 
to determine whether cardiac function is rhythmic or arrhythmic. Electrical mapping techniques, 
by using surface electrodes, have been used to study the spread of cardiac excitation, but the two 
most basic characteristics, activation and recovery, cannot be identified reliably at the site of 
recording for conditions other than uniform propagation. In addition, it is not possible to map 
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while a defibrillating shock is being applied and during slowly changing, low-level 
depolarization, which is seen in ischemia. Repolarization measured with an electrogram often 
does not coincide with the actual repolarization at the recording site. Since Salama and Morad 
for the first time made optical recordings of cardiac AP in 1976, the optical measurements of 
cardiac APs from the cellular to organ level have made a crucial contribution to cardiac 
research.[118] The principal theory of optical recordings of cardiac AP is that a membrane 
binding potentiometric fluorescent dye changes its spectral properties in response to changes in 
membrane potential. In other words, a membrane binding voltage sensitive dye exhibits 
wavelength shifts in peak fluorescence and/or absorption due to a change in membrane potential. 
The major advantages of optical mapping are thought to be 1) the impervious response to 
electrical defibrillation shock, 2) the fast response to voltage changes, and 3) the high 
spatiotemporal resolution.[119] In addition to optical recordings of cardiac AP with 
potentiometric probes, the optical measurements of changes in ion concentration have been 
widely performed. For example, changes in Ca
2+
 concentration inside cardiomyocytes have been 
measured with Ca
2+
 sensitive fluorescent probes such as Ca
2+
 indicators Rhod-2 AM and fluo-
4.[120, 121]Recently, simultaneous optical measurements of cardiac AP and Cai dynamics at 
high spatial and temporal resolution have been performed and provide a powerful tool to 
investigate the role of Cai anomalies in eliciting cardiac arrhythmias (see Figure 6).  
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Figure 6. Examples of simultaneous measurement of AP (blue) and Cai (red) dynamics in a 
Langendorff perfused rabbit heart before and after inhibition of IKr LQT2 was modeled by 
perfusing with Tyrode‟s solution containing dofetilide (250 to 500 nM, Pfizer, New York, NY), a 
selective IKr blocker and lowering K
+
 and Mg
2+
 concentrations by 50 %. A) Baseline recording at 
500ms cycle length (CL). B) Baseline recording at 1200ms CL. C) 2 minutes after dofetilide 
infusion at 1200ms CL. D) 5 minutes after dofetilide infusion at 1200ms CL.  
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3.5 AGENTS TARGETING ABNORMAL Ca
2+ 
HANDLING 
Spontaneous SR Ca
2+
 release under diverse pathological conditions has been linked to 
initiation of cardiac arrhythmias, and suppression of the SCR has been considered as possible 
anti-arrhythmic therapies.[122, 123] So far, several pharmacological agents have been 
introduced as SCR suppressors, though their therapeutic strategies may differ.  
JTV519, also known as K201 stabilizes RyR2 in the closed state by enhancing the binding 
affinity of calstabin 2 for RyR2 and preventing the dissociation of calstabin 2 from RyR2.[124] It 
has been tested in ischemia injury models.[125] Flecainide, which is a well known Na
+
 channel 
blocker, also suppresses SCR by inhibiting RyR2 channels by open state block, and has been 
tested in CPVT mutation.[126] Captopril, which was introduced as an angiotensin converting 
enzyme inhibitor, acts as a reducing agent and thus reduces SCR by protecting against ischemia-
induced oxidation.[127] 
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4.0 BRADYCARDIA INDUCES NON-UNIFORM SECONDARY Ca
2+
 RELEASE THAT 
ENHANCES ACTION POTENTIAL DURATION, DISPERSION OF 
REPOLARIZATION AND ARRHYTHMIA RISK 
In heart muscle, the influx and efflux of Ca
2+ 
across the plasma membrane are precisely 
balanced during each phasic contraction as is the coordinated Ca
2+
 release and reuptake across 
the sarcoplasmic reticulum (SR) network. Any deviation or imbalance between influx and efflux 
can only be small and transient to maintain cytoplasmic Ca
2+
 homeostasis.[128] A fundamental 
property of mammalian hearts is the force-frequency relationship or „Staircase Effect‟ where a 
change in heart rate causes a transient imbalance between Ca
2+ 
influx and efflux until a new 
steady state is attained where again Ca
2+
 influx equals efflux but at a new state of contractility. 
The stair case effect is associated with an inverse relationship between action potential (AP) 
duration (APD) and heart rate (HR) which is critical to achieve a stable state of contractility. The 
mechanism responsible for APD adaptation as a function of HR remains controversial. Most 
studies attribute APD adaptation to changes in cytosolic Ca
2+
 [2] which in turn alters the kinetics 
of Ca
2+
-dependent inactivation of L-type Ca
2+
 channels[64, 65, 106] but others have implicated 
the rate-dependence of Na-Ca exchange current, INCX[107] and of the late Na
+
 current, INa,L.[108] 
Besides ion channel kinetics, changes in ionic concentrations in the cytoplasm (intracellular Na
+
 
and Cai) or extracellular K
+
 contribute to APD adaptation.[109, 110] Mathematical simulations 
of slow HR indicated that the long diastolic intervals result in a complete deactivation of the 
slow component of the delayed rectifying K
+ 
current (IKs) and complete recovery from 
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inactivation of L-type Ca
2+
currents (ICa,L) which could theoretically explain APD adaptation in 
bradycardia.[111-113] 
Of all the proposed explanations for APD adaptation, the role of Cai cannot be over- 
emphasized since independent of rate, APD is inversely dependent on external [Ca
2+
] and Cai by 
one of the mechanisms that mediate Cai → Vm coupling. During a transition from slow to fast 
HRs, Cai rises due to the greater number of APs per unit time and decreased Ca
2+
 efflux due to 
shorter diastolic intervals. Higher Cai accelerates the Ca
2+
-dependent inactivation of ICa,L , 
reduces Ca
2+
 influx per AP which decreases APD; an important negative feedback process that 
limits total Ca
2+
 influx via ICa,L[129] and enables the system to reach a new steady state. 
Conversely, a transition from fast to slow HR slows down Ca
2+
 dependent ICa,L inactivation and 
the long diastolic intervals allow for the complete recovery of ICa,L from inactivation which 
prolong APDs. 
HR regulates force generation in a physiological range of HRs but fast or slow HRs create 
severe Ca
2+
 handling abnormalities that in combination with various pathologies promote 
arrhythmias.[130] Transitions from slow to fast HR have been extensively studied and shown to 
create Ca
2+ 
alternans that lead to APD and T-wave alternans and arrhythmias. [26] In the setting 
of ischemia[22, 131] and heart failure[132], arrhythmogenic Ca
2+
 and APD alternans occurred at 
physiological HR. In contrast, few studies have investigated events associated with bradycardia 
even though bradycardia is known to be an important co-factor required to trigger Torsade de 
Pointes in long QT types 2 and 3. In drug-induced long QT type 2 (LQT2), slow HR promotes 
spontaneous SR Ca
2+
 release that occurs during the AP plateau to produce early 
afterdepolarizations (EADs) that progress to Torsade de Pointes. [11, 16] At the level of intact 
hearts, bradycardia prolongs APD but also enhances dispersion of repolarization (DOR),[90, 
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115] and the enhanced DOR is thought to be a contributing factor to maintain LQT2-related 
arrhythmias.[133] In ventricular cells, the longer the cycle length the greater the APD 
prolongation but in intact hearts, the mechanism linking bradycardia to enhanced DOR and 
arrhythmia vulnerability remains unexplored. 
This project investigates APD adaptation during bradycardia in Langendorff perfused rabbit 
hearts using dual optical mapping of Cai and Vm with high resolution CMOS Cameras. The data 
shows for the first time that bradycardia produces a spatially heterogeneous secondary Ca
2+
 
release (SCR) from the SR which modulates APD through Cai→ Vm coupling and correlates 
with the enhanced dispersion of APD and DOR.  
4.1 METHODS 
4.1.1 Heart preparations 
New Zealand White rabbits (15 female, 60 to 120 days old) were euthanized with 
pentobarbital (75 mg/kg intravenously) and anticoagulated with heparin (200 U/kg 
intravenously). The heart was rapidly dissected and perfused with Tyrode‟s solution containing 
(in mM): 130 NaCl, 24 NaHCO3, 1.0 MgCl2, 4 KCl, 1.2 NaH2PO4, 50 dextrose, 1.25 CaCl2, at 
pH 7.2-7.4, gassed with 95% O2 plus 5 % CO2. Temperature was maintained at 37.0 °C and 
perfusion pressure was adjusted to ≈70 mmHg with a peristaltic pump. To minimize motion 
artifact, blebbistatin (Sigma, St Louis, MO 5-10 μM) was added to the perfusate for 5-10 min. 
The heart was immobilized in a chamber and stained with a voltage-sensitive dye (PGH1: 200 μl 
of 1 mg/ml dimethyl sulfoxide (DMSO)) and loaded with a Ca
2+
 indicator (Rhod-2 AM, 200 μl 
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of 1 mg/ml DMSO). Epicardial bipolar pseudo-EKG was continuously monitored. Epicardial 
pacing with a unipolar electrode on the right ventricle was performed at a baseline cycle length 
of 0.5 seconds (baseline heart rate (BHR) of 120 beats/minute) or at a slow HR (SHR) with a 
cycle length of 1.2 seconds (50 beats/minute; profound bradycardia for rabbit hearts). This 
investigation conformed to the current Guide for Care and Use of Laboratory Animals published 
by the National Institutes of Health the Institutional Animal Care and Use Committee of the 
University of Pittsburgh. 
4.1.2 Optical apparatus 
An optical apparatus consisting of two CMOS Cameras (SciMedia, Ultima One, 100 by 100 
pixels, at 250 frames per second) has been used for simultaneous measurement of intracellular 
Ca
2+
transients and membrane potential changes, as previously described.[134] The anterior 
surface of the heart was illuminated with a 520 ± 30 nm excitation beam, and the fluorescence 
was passed through a dichroic mirror (660 nm) to focus the Rhod-2 and PGH1 fluorescence 
images on two CMOS Cameras.[134]  
4.1.3 Study protocol 
The AV node was ablated by cauterization to control heart rate. Hearts were paced at a cycle 
length of 0.5 s which was taken as a ‘baseline heart rate’ (BHR) then the cycle length was 
lengthened to 1.2 s to impose a bradycardia or a ‘slow heart rate’ (SHR). APs and CaiT were 
continuously recorded for 32 s during transitions from fast to slow or slow to fast HRs while 
measuring changes in AP duration (APD). Changes in HR lead to gradual changes in APD until 
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a new steady state was attained. The time-course of „APD adaptation‟ required continuous 
recordings of 3-5 minutes to reach a steady state of APDs during transitions from BHR to SHR 
(bradycardia) and 5-10 minutes in going from SHR to BHR. 
Pilot experiments were carried out to select the BHR and the SHR that were used in this 
study. A slow heart rate of 50 beats/min was chosen because it could be maintained reliably 
without interruptions by an occasional extra-beat yet was effective to expose spatial 
heterogeneities of CaiT caused by SCR. Similar, but less pronounced effects were observed at 
0.9 and 1.0 s cycle lengths. A basic heart rate of 120 beats/min was chosen because a) this HR 
was well tolerated and did not result in „run-down‟ of the preparations, b) capture with pacing 
electrodes was reliable during uninterrupted recordings and c) spatial heterogeneities of AP and 
CaiT were negligible compared to still faster rates.  
4.1.4 Data analysis 
T wave (TW) amplitude relative to QRS complex (TW/QRS) in EKG was used to 
approximate DOR. [135] Activation time at each site was calculated from (dF/dt)max of the local 
AP or CaiT upstroke. APD and CaiT duration (CaiTD) at each site was calculated from the 
interval between (dF/dt)max and the recovery of Vm and CaiT traces to 20% of baseline (APD80 or 
CaiTD80), respectively. Automatic measurement of APD80 and CaiTD80 from all pixels (100 x 
100 pixels) was used to calculate mean APD80 and CaiTD80. The dispersion of APD80 and 
CaiTD80 was calculated from the SD of APD and CaiTD. The time constant (τ) of mean APD 
(from all 100x100 pixels) adaptation to heart rate changes was calculated by fitting the 
transitions from BHR to SHR (τf→s) and from SHR to BHR (τs→f ) with mono-exponential 
functions. Briefly, the root mean square of differences between measured and predicted APD 
 28 
values were used to choose the best curve fit. Rate and time dependent mean APD80 and CaiTD80 
and regional variation in 100 x 100 pixels were statistically evaluated. Bradycardia dependent 
AP/CaiT prolongation and dispersions before and after K201 (1 µM) or flecainide (5 µM) 
perfusion were compared. K201 (3-(4-Benzylcyclohexyl)-1-(7-methoxy-2,3-
dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)propan-1-one) was synthesized according to the 
procedure reported by Wehrens et al.[136] The area under the curve [137] of CaiT at each pixel 
was normalized by setting the minimum value to zero and the maximum AUC to 1. Maps of 
AUC were generated at steady state BHR and SHR. AUC was used as a measurement of the 
relative Cai at each site. Scatter plots of AUC versus APD80 were used to correlate these two 
parameters and calculate a correlation coefficient (r) between AUC and APD80 at steady state 
SHR. All 10,000 recordings (100x100 pixels) were used to generate the scatter plots to correlate 
spatial heterogeneities of SCR to the dispersion of APD80. Regional differences, base of right 
ventricle (RVB) and apex of left ventricle (LVA) were compared for statistical significance 
using 2-tailed t-test. Box-whisker diagrams are used to visualize the distribution of the data. The 
top and bottom whiskers define respectively the maximum and minimum values; the top and 
bottom of the box define the 75
th
 and 25
th
 percentiles respectively and the line within the box is 
the median in the data set. 
4.1.5 Western blot Analysis 
Female New Zealand White rabbits (3 month old) were euthanized, as described above; the 
hearts were perfused with Tyrode‟s solution and ventricular tissue samples (~50 mg) were 
dissected from the anterior RVB and LVA corresponding to “RVB” and “LVA” regions of the 
optical mapping studies. Proteins were isolated as previously described,[138] were separated by 
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SDS-PAGE (50 µg/ sample), transferred to PVDF membranes which were probed by standard 
techniques. After immunolabeling, band intensities were measured with Image J and normalized 
with respect to β actin. Differences between the RVB and LVA were analyzed with one-tailed t-
test and considered significant at p< 0.05. Antibodies against Cav1.2α, SERCA2, ERG and β 
actin were obtained from Santa Cruz Biotech (Cat. #: SC-103588, SC53010, 15968 and 81178, 
respectively); NCX1, and RyR2 were obtained from Thermo Scientific (Cat. #: MA3-926 and 
MA3-916, respectively) and Nav1.5 was obtained from Alomone (Cat. #: ASC-005)  
4.2 RESULTS 
APD80 adaptation was reproducible from heart to heart and during repeated cycles (3-4 per 
heart) of transitions from 120 (BHR) to 50 (SHR) beats/min and back. Figure 7 A illustrates a 
sequence of two complete cycles of APD adaptation from BHR to SHR. From a steady state 
heart rate of 120 beats/min (not shown), a transition from BHR to SHR resulted in the expected 
gradual APD80 and QT prolongation which was fully reversed by shifting back to BHR. The 
mean ΔAPD80 in the first episode of 5 minutes of sustained SHR increased by 55.2±10.9% which 
was similar to % increase in the mean ΔAPD80 recorded in second episode of SHR (51.25±8.2%) 
(p>0.05, n=4). Panels B and C illustrate optical APs and an EKG recording from bipolar surface 
electrodes, respectively measured at various time points (labeled: a-e in Figure 7A). An AP 
recorded at the onset SHR (trace a) is markedly shorter than at steady state SHR (trace b). APs 
measured at the next set of steady state BHR (traces c and e) are shorter than at steady state SHR 
(trace d). Similarly, T-wave amplitudes were markedly larger at steady state SHR (arrows on 
traces b and d) than at BHR (arrows on traces c and e) or the initiation of SHR (arrow on trace a) 
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(Figure 7C). The increases in T-wave amplitude relative to the QRS amplitude are a measure of 
enhanced DOR and the ratio of TW/QRS amplitude was statistically greater at steady state SHR 
than BHR (Figure 7C right panel, p<0.01, n=15 trials from 5 hearts). 
 
Figure 7. APD80 adaptation during transitions from BHR and SHR A) Repeated cycles of 
pacing from SHR to BHR. Changes in HR (top trace) and the time course of APD80 adaptation 
are shown uninterrupted for 22,000 seconds. B) Optical traces of APs from one of the pixels on 
the CMOS camera were measured at various time points: a, b, c, d and e, as labeled in panel A 
(top trace). C) EKG signals were recorded from the epicardium at the same time points: a, b, c, d 
and e, as depicted in panel A (top trace). The relative amplitude of T-waves measured as the ratio 
of TW to QRS amplitudes was statistically greater in SHR than BHR which is indicative of an 
increase in DOR.  
 
APD80 adaptation curves showed different time constants in going from BHR to SHR (τf→s = 
48±9.2s) compared to from SHR to BHR (τs→f =30.4±4.7s; p<0.05, n=5 hearts) (Figure 8).  
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Figure 8. Time constants for APD80 adaptation: from BHR to SHR and SHR to BHR A) 
APD80 adaptation during transitions from SHR to BHR. B) APD80 adaptation during transition 
from BHR to SHR. In both cases, the time course of APD80 adaptation to changes of cycle 
on the best-fit of experimentally measured APD80 adaptations. 
 
  At BHR, AP and CaiT signals exhibited the expected rapid rise and monophasic 
recovery to baseline. During the transition to SHR, diastolic levels of Cai decreased gradually 
and APD80 and CaiTD80 exhibited the expected time-dependent prolongation (Figure 9A). Most 
interesting was the gradual prolongation of CaiTD80 which was associated with an increasingly 
more pronounced “secondary Ca2+ rise” (SCR) during the AP plateau and was associated with 
APD prolongation (Figure 9A, SCR labeled with an arrow, right traces). With slow pacing, 
APDs and CaiTDs increased gradually reached a new steady state. The rate dependent, gradual 
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increase of SCRs (arrow from BHR to SHR) was associated with changes in the shape and time-
course of APs, with a linear relationship between CaiTD80 and APD80 (Figure 9A bottom panels). 
Note the gradual prolongation of Cai (arrow from short to long durations) and voltage (Vm) 
traces from BHR, to 16s and 5 min of SHR. Reversal to BHR suppressed SCR gradually, altered 
the shape of AP repolarization and shortened APD80 and CaiTD80 (arrow from long to short 
duration) (Figure 9B). During APD adaptation, there was a linear relationship between APD80 
and CaiTD80 during the transition from BHR to SHR (Figure 9A bottom traces) and from SHR to 
BHR (Figure 9B bottom traces).  
The distribution of SCR was heterogeneous and was more pronounced at the bast of the right 
ventricle (RVB) than the apex of the left ventricle (LVA) as was the distribution of APDs. Figure 
10A shows an image of a heart and the area viewed by the CMOS Camera, delineated by the 
black box. Maps of APD80 (Figure 10B top panels) and CaiTD (Figure 10B bottom panels) are 
shown for BHR and 32 s and 5 min into SHR. SHR Caused a marked increase in the dispersion 
of both APD80 and CaiTD80 compared to steady-state BHR (p < 0.01, n = 7 hearts) (Figure 10B 
and D). The superposition of CaiT measured at BHR, 32 s and 5 min of SHR are shown for three 
sites (a, b and c) on the anterior surface (Panel A). The traces show that SCR and CaiTD80 
increase during APD adaptation from BHR to SHR in a spatially inhomogeneous, being more 
pronounced at site a on the RVB than sites b and c that are closer to the LVA (Figure 10C). 
Similarly, the standard deviations [122] of CaiTD80 and APD80 were significantly greater in SHR 
than BHR (p<0.01, n=7 hearts, Figure 10D).  
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Figure 9. Time-course of APD and CaiTD adaptation during first 32 seconds. A) Changes in 
AP and Cai dynamics during a change in heart rate from BHR to SHR (top traces). APD80 and 
CaiTD80 are plotted as a function of time and APD80 vs. CaiTD reveals a tight linearly 
relationship. Inset: superposition of APs and CaiTs from the same pixel recorded at different 
times during adaptation to SHR  B) Changes in AP and Cai dynamics during the reversal from 
SHR to BHR. APD80 and CaiTD80 are plotted as a function of time and APD80 vs. CaiTD are 
linearly related. Inset: superposition of APs and CaiTs from the same pixel recorded at different 
times during adaptation towards BHR. 
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Figure 10. Dispersion of CaiTD80 and APD80 in BHR and SHR A) A picture of the heart with 
a black box identifying the region of the heart viewed by the CMOS cameras. B) Dispersion of 
APD80 (top panels) and CaiTD80 (bottom panels) at different time-points from steady state BHR 
(left panels) to SHR after 32 s (middle panels) and at equilibrium 5 min (right panels). C) Optical 
traces of Cai at site a, b and c, that are identified panel A. D) Standard deviation [122] of CaiTD80 
(top) and APD80 (bottom) at steady state BHR and SHR. SDs were calculated from 10,000 
recordings (100 x 100 pixels) at 120 beats per minute (bpm) baseline and 5 minute at 50 bpm.  
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Since the comparison between amplitudes of CaiT and APD is widely used to show the 
impact of Ca
2+
 abnormality on APD prolongation or shortening, correlation of areas under curves 
(AUCs) of CaiT, which approximate amplitudes of SCRs, with APD80 was calculated to assess 
the interplay between Cai and Vm. Maps of AUCs and APD80 were generated and correlation 
coefficients were Calculated from scatter plots of AUC vs. APD80.  Figure 11A shows the region 
of a heart viewed by the arrays and Figure 11B and C show the correlation analysis during BHR 
and SHR, respectively from the same heart. The scatter plot of AUC vs. APD80 (Figure 11C, 
rightmost panel) exposes a particularly poor correlation with r = 0.243 during BHR. In contrast, 
scatter plots during SHR (Figure 11D, rightmost panel) show a tight correlation with a 
coefficient r = 0.924. Figure 11D illustrates results from a second heart during SHR where AUCs 
and APD80 were greater in amplitude at the RVB than the LVA and the correlation coefficient of 
AUCs vs. APD80 was 0.987. The hearts in Figure 11A and D were chosen to illustrate the two 
types of scatter plots that were observed; either a rare bifurcation or non-monotonic AUC vs. 
APD80 relationship (n=1/5) (Figure 11D, rightmost panel) or a monotonic relationship (Figure 
11C, n=4/5). Most interesting was the enhanced correlation between AUC and APD80 in SHR (r 
= 0.93 ± 0.03)  compared to that in BHR (r = 0.55±0.29) (p < 0.01, n = 7 hearts) (Figure 11E). 
The mean APD80 at BHR was not significantly different between RVB and LVA (p>0.29, n=7) 
but became statistically different at SHR (p<0.05, n=7) (Figure 11F). In SHR, AUCs were 
significantly greater at the RVB than the LVA, as shown in AUC maps in Figure 11C and D 
(p<0.05, n=5). 
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Figure 11. Regional differences of APD80 and AUC of CaiT in bradycardia A) Image of 
heart with a box to delineate the field-of-view of the cameras. B) Maps of AUC (of CaiT) and of 
APD80 during BHR with scatter plot of AUC vs. APD80, in this case the correlation coefficient, 
r= 0.243. C) Same heart as in B but during SHR, maps of AUC and APD80 exhibit large regional 
variations from RVB to LVA, arrows depict gradients of large to small AUC and APD80, AUC 
vs. APD80 scatter plot was non-monotonic, with r = 0.924. D) As in C but with a different heart. 
The field-of-view is delineated by the box and maps of AUC and APD80 exhibit marked 
regional variations from RVB to LVA, arrows identify direction of long to short CaiT and APD80. 
Scatter plot of AUC vs. APD80 was monotonic with r= 0.987.  E)  Summary analysis of r values 
showing a higher correlation between AUC and APD80 at SHR than BHR, p< 0.01 n=7 hearts.  
F) Statistical analysis of APD80 comparison between RVB and LVA during BHR (p=0.29, NS) 
after 5 min of SHR (p<0.05 n = 5 hearts); SHR results in statistically significant increase in APD 
at the base than apex and the percent change in APD, ΔAPD80 increased by 80% in RVB 
compared to 40% in LVA as a result of the bradycardia.  
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To elucidate the interplay between intracellular Ca
2+
 and voltage, experiments were 
carried out to assess whether SCR prolonged APDs or prolonged APDs elicited SCRs. In SHR, 
SCRs are more pronounced and it is reasonable to expect that SCRs might originate from a 
„second‟ release of Ca2+ from the SR via cardiac ryanodine receptors (RyR2). Two agents known 
to stabilize RyR2, K201 (1µM, n=5) and flecainide (5 µM, n=4) were perfused to test their 
effects on SCR as well as APD and CaiTD adaptation. CaiTD and APD adaptation was measured 
during transitions from BHR to SHR before and after perfusion with K201 or flecainide. Plots of 
the percent change of mean ΔAPD80 as a function of time are shown during transitions from 
BHR to SHR for 24 pixels on the LVA and 24 pixels on the RVB, before and after perfusion 
with a RyR2 stabilizer. As shown in Figure 12, K201 (panel A) and flecainide (panel B) 
suppressed SCR and CaiTD during SHR (Cai traces without or with K201 or with flecainide, 
respectively in Figure 12A and B) and reduced mean APD80 (Vm traces in Figure 12A and B) at 
pixels on the RVB (K201: p < 0.01, n=5; flecainide: p < 0.01, n=4) (Figure 12A and B left 
graphs of ΔAPD80 % vs. time). In contrast to their effect on SCR at the base during SHR, K201 
and flecainide did not significantly change AP and CaiT at the apex during SHR (Figure 12). It is 
important to note that K201 and flecainide did not significantly alter the early phase of APD 
adaptation, meaning the first 10 s of APD prolongation but both suppressed a second phase of 
APD prolongation from 10-25 s (plots of ΔAPD80 % vs. time, Figure 12A and B). As shown in 
Figure 13, the suppression of SCR by K201 (1 µM) or flecainide (5 µM) markedly reduced the 
dispersion of APD80 at SHR (K201: p < 0.05, n=5; flecainide: p < 0.05, n=4).  
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Figure 12. Suppression of SCR by K201 and flecainide A) Percent change of APD80 as a 
function of time during adaptation to SHR for sites on the LVA (top graph) and sites on the RVB 
(bottom graph) before and after perfusion with 1μM K201; traces of Cai and voltage (Vm) are 
superimposed for BHR and SHR without (top traces) and with K201 (bottom traces). Right 
graph, plots the summary data (n = 5 hearts) of the % change in ΔAPD80 for hearts without 
(control) and with K210 (1 µM). B) As for panel A but using flecainide (5 µM) instead of K201. 
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Figure 13. Suppression of SCR reduces DOR A)Maps of APD80 (in ms) before (left panel) and 
after perfusion with K201 (1μM) (middle panel) at SHR, the standard deviation is used to 
quantitatively measure the dispersion of APD80. Which is significantly greater in controls (ctlr) 
before K201 than after K201 (right panel) B) Maps of APD80 (in ms) before (left panel) and after 
perfusion with flecainide (5μM) (middle panel) at SHR, the standard deviation is used to 
quantitatively measure the dispersion of APD80. Which is significantly greater in controls (ctlr) 
before than after flecainide (right panel)  
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The higher occurrence of SCR at the RVB compared to LVA was possibly due to intrinsic 
differences in the expression of ionic channels and/or transporters. As shown in Figure 14, the 
expressions of L-type Ca
2+
 channel, NCX and voltage-gated Na
+
 channel, Nav1.5 proteins were 
significantly higher at RBV than LVA (p<0.05; n=7). In contrast, the levels of SERCA2A, RyR2 
and RERG (Rabbit-ERG) were not significantly different (p>0.05; n= 7 hearts). In 5 out of 15 
hearts, bradycardia alone was sufficient to produce premature ectopic beats (Figure 15B and D), 
which were readily eliminated by pacing at BHR (Figure 15C and E). Likewise inhibition of 
SCR with 1µM of K201 suppressed the onset of ectopic beats at steady state bradycardia (Figure 
15F).  
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Figure 14. Heterogeneities of Ion Channels and Transporters between RVB and LVA 
Ventricular tissues were dissected from the epicardium at the base of the RV (RVB) and the apex 
of the LV (LVA) and processed for Western blots as described in „Methods‟. Density of peptides 
was normalized with respect to β-actin to compare levels of channel proteins between RV and 
LV. A: Illustrates the relative density of RVB versus LVA densities for Cav1.2α, NCX2 
(dominant isoform of NCX in heart), SERCA2A, RyR2 and RERG (rabbit ERG). B: Summary 
of density histograms for each of these channel protein showing a highly significant 2-fold 
upregulation of Cav1.2α and NCX2 at RVB compared to LVA (p<0.05, n=7 hearts). There were 
no significant differences between RVB and LVA for SERCA2A, RyR2 and RERG (p>0.05, 
n=7 hearts).    
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Figure 15. Bradycardia-dependent ectopic beats A) A pacing protocol consisting of 2-cycles 
of BHR to SHR with 5 min intervals to achieve steady state followed by treatment with K201 
and another cycle to examine the effects of RyR2 stabilization. Red arrows indicate the timing of 
changes in HR from BHR to SHR, and green arrows indicate changes from SHR to BHR. B & 
D) Premature ectopic beats were reproducible during the two episodes of bradycardia at 3 min 
and 13 min of the experiment. C & E) The termination of ectopic beats was consistently obtained 
during the episode of BHR, shown here at 8 and 18 min time points. F) After pretreatment with 
K201 (1µM), bradycardia-dependent ectopic beats were suppressed. 
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4.3 DISCUSSION 
Change in heart rate is one of the main mechanisms used by mammals to adjust cardiac 
output to changing demand. The adaptive role of tachycardia in a “fight-or-flight” situation is 
well accepted as are the beneficial effects of bradycardia during sleep which diminishes energy 
consumption by the myocardial tissue. Several parameters of cardiac contraction have to adjust 
to dynamic HR changes. Most prominent is the change in the duration of mechanical (and 
electrical) systole to maintain an acceptable balance between the time for ventricular ejection and 
ventricular filling. At the cellular level, this requires shortening of APD and CaiT in response to 
HR increase.  
4.3.1 Effects of HR ‘in and out’ of the physiological range  
It is not surprising that unusually rapid or slow heart rates contribute to electrical 
instability and abnormal Ca
2+
 handling by ventricular myocytes has been implicated as a 
contributor to this instability. For example, an extensive body of clinical literature suggests that 
microvolt T-wave alternans (mTWA) is a predictor of ventricular arrhythmias in a wide range of 
conditions.[139-141] mTWA is known to be a tachycardia-related phenomenon, induced by 
either exercise or atrial pacing for the purposes of clinical testing.[142] At the cellular level, AP 
alternans underlies mTWA and is preceded by CaiT alternans,[27] which presumably causes AP 
alternans by changing the NCX current or similar processes that influences Vm → Cai  coupling 
as well the reverse Cai → Vm coupling.[143, 144]  
Slow ventricular rate is likewise a critical pro-arrhythmic co-factor known to increase 
propensity to Torsade de Pointes (TdP), a polymorphic ventricular tachycardia associated with 
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delayed repolarization.[25, 145] In patients with recurrent bouts of TdP, pacing at relatively fast 
rates is an effective therapeutic maneuver.[146] Abnormal Ca
2+
 handling and spontaneous SR 
Ca
2+ 
release or ICa,L reactivation are widely accepted as the mechanism of early 
afterdepolarizations (EADs), the triggered activity which underlies TdP.[14, 81, 147] We have 
recently reported that in a rabbit model of long QT type-2 related TdP involving bradycardia and 
IKr block, oscillations of CaiT develop during APD prolongation and precede the appearance of 
EADs by minutes.[148] The data suggest that the Cai oscillations are caused by spontaneous SR 
Ca
2+
 release that activates a depolarizing NCX current that serves as a trigger to EAD generation. 
Although IKr block with dofetilide was required for the appearance of extra Cai upstrokes, we 
observed that bradycardia alone caused a delay or a “plateau” in the normally smooth downslope 
of CaiT. This CaiT delay could be eliminated by increasing pacing rate. The experiments 
reported in this paper were motivated by an effort to elucidate the relationship between 
bradycardia, Ca
2+
 handling and arrhythmogenesis. 
4.3.2 Why is bradycardia arrhythmogenic? 
Bradycardia has long been known to prolong APDs and enhance DOR, setting the stage for a 
more arrhythmogenic substrate with a greater propensity to functional reentry but the 
mechanisms that enhance DOR are not fully appreciated. Here, we report that bradycardia 
produces the expected gradual decrease of diastolic Cai but also show for the first time that 
bradycardia promotes ‘secondary Ca2+ release’ (thus labeled SCR) which is non-uniform on the 
epicardium and contributes to APD adaptation. SCR differs from spontaneous Ca
2+
 release and 
Ca
2+
 oscillations because the latter can occur at various times along the AP plateau or even 
diastole which can lead to the initiation of early and delayed afterdepolarizations, respectively. 
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Bradycardia-dependent SCR occur as extra Ca
2+
 release 200-300 ms after the AP upstroke, 
prolong CaiTDs, are more pronounced at the RVB and are associated with a delay of ventricular 
repolarization. The repolarization delay is most likely caused by SCR in response to a change in 
HR and correlates closely with the spatial and temporal changes in APD. 
To address the question whether CaiT changes drive AP changes or vice versa, we performed 
experiments with K201 and flecainide, agents known to specifically stabilize RyR2. Both agents 
eliminated SCR and attenuated AP prolongation and DOR during bradycardia. Both agents have 
off-target effects which must be carefully considered. K201 (1 µM) inhibited INa, ICa,L and IKr in 
addition to its effect on RyR2 but these findings in guinea pig myocytes appear to be species 
dependent.[149, 150] In rabbit myocytes, K201 was fairly specific for RyR2, at 1 µM; it reduced 
spontaneous SR Ca
2+
 release and Ca
2+
 waves without altering ICa,L and SR Ca
2+
 content. [151] 
Flecainide at 5 µM targets voltage-gated Na
+
 channels which would reduce intracellular Na
+
 and 
Ca
2+
 load, produce the negative inotropic effect reported for class I anti-arrhythmics[152] which 
would be expected to prolong not shorten APDs. Flecainide inhibits RyR2 by binding to the open 
state of the release channel[153] and with respect to APD prolongation; its effect on INa normally 
outweighs[154-156] its inhibitory effect on IKr. [152] Here, both agents reduce bradycardia-
induced APD prolongation which argues that both agents primarily suppress SCR originating 
from the SR Ca
2+
 release by stabilizing RyR2 and not by off-targets effects that would prolong 
APD. Another compelling argument is that both reduce APD in bradycardia but only at the RVB 
and have no effect at the LVA or during normal HR. A similar argument suggests a role for SCR 
in bradycardia-induced DOR and the suppression of DOR by K201 and flecainide. It is likely 
that the dramatic changes in CaiT morphology observed before TdP onset in our LQT2 model 
represent  accentuation of a “normal” CaiT response to profound bradycardia. 
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We have observed that elimination of SCR by K201 blunts a second slow phase of APD 
prolongation in response to bradycardia. It thus appears that the dynamics of Ca
2+
 handling by 
ventricular myocytes is another candidate mechanism for AP adaptation to HR change, in 
addition to the mechanisms mentioned in the introduction. Most likely, the Cai handling affects 
APD by means of Cai →Vm coupling most likely via NCX. This effect seems to function during 
bradycardia since the area under the curve of CaiT was tightly correlated to APD80, as both 
varied as a function of time and location until steady state bradycardia was reached (Figure 11). 
A major difference between CaiT measured during baseline and slow HR is the appearance of 
SCR which implies that SCRs influence APDs. The weak correlation between AUCs and APDs 
in BHR suggests independence between the two parameters and implies that Cai has little effect 
on the plateau potential and repolarizing K
+
 currents. In contrast, SCR in bradycardia augments 
the forward mode of INCX, enhances Cai → Vm coupling and prolongs APDs leading to a high 
correlation between AUC and APDs. The linear scatter plots suggest that the spatial 
heterogeneity of AUC is an important determinant of APD80 dispersion. QT adaptation time 
constants measured in human hearts were comparable in magnitude and exhibited a similar 
trend.[157] 
The enhanced correlation of CaiT and APD80 in bradycardia suggests that SCR raises Cai 
levels during the AP plateau, which stimulates the forward mode of NCX and its depolarizing 
current, INCX which raises the plateau potential and prolongs APDs. In the absence of adrenergic 
activity, SCRs were attributed to the re-activation of RyR2 which would be caused by a higher 
level of SR Ca
2+
 in a spatially non-uniform manner. The mechanism underlying the regional 
distribution of SCRs was due to higher levels of expression of Cav1.2α, NCX1 and Nav1.5 (but 
not RyR2, SERCA2A or RERG) at the RVB than the LVA. In previous reports, we had shown 
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that in adult female rabbit hearts Cav1.2α and NCX1 were upregulated at the base compared to 
the apex of left ventricles. The higher levels of mRNA and proteins corresponded to higher 
levels of their respective current densities ICa,L and INCX, measured by patch-clamping myocytes 
isolated from the base and apex.[138, 158] Higher Nav1.5 at the base could contribute to the 
higher Ca
2+
 load by increasing intracellular Na
+
 leading to a stimulation of reverse mode and 
inhibition of the forward mode of INCX.     
The mechanism through which bradycardia promotes SCR is uncertain at this moment. In 
principle, increased diastolic interval during bradycardia should allow more time for Cai removal 
out of the cell by NCX. However, SR Ca
2+
 pumps can compete effectively with NCX for the 
removal of Cai during bradycardia. The amount of Cai transported to the lumen of the SR by 
SERCA during each cardiac cycle may actually be higher during bradycardia due to: a) longer 
AP plateau, b) longer duration of Ca
2+
 influx through L-type channels and c) the reduced NCX 
driving force during more positive plateau potentials. If there is a significant diffusion limitation 
of Ca
2+
 movement between the uptake and release SR compartments, junctional SR may be 
replenished after the initial phase of Ca
2+
-induced Ca
2+
-release from the non-junctional 
compartment during each heartbeat to a degree which allows spontaneous Ca
2+
 release through 
RyR2 in at least some myocytes. This process should be augmented by any intervention which 
prolongs plateau duration, such as IKr blockade. 
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4.4 STUDY LIMITATIONS 
The study focused on the epicardium and did not investigate SCR from different regions of 
the ventricles. Although previous studies demonstrated higher levels of ICa,L and INCX occurred at 
the base of the rabbit epicardium and not the apex or the endocardium,[138, 158] we cannot 
exclude the possibility of SCR in other regions of the heart. The study provides evidence that 
bradycardia increases Ca
2+
 in the lumen of the SR in a non-uniform manner resulting in a SCR at 
the base, and APD prolongation mediated by INCX. Pilot studies attempted to demonstrate the 
contribution of NCX to APD prolongation during bradycardia. Unfortunately, the available NCX 
inhibitors are not sufficiently selective or effective at blocking NCX. Trials with SEA0400 (0.1-2 
µM) to block the forward mode of NCX were inconclusive because at these concentrations, 
inhibition of NCX is partial and at concentrations > 1 µM, ICa,L is progressively suppressed.[159] 
An alternative approach of lowering external Na
+
 has been successfully used to inhibit INCX in 
isolated myocytes but cannot be applied fast enough in perfused hearts. Likewise, caffeine can be 
effectively use to estimate SR Ca
2+
 load in isolated myocytes but not in perfused hearts. 
Nevertheless, these limitations do not detract from the validity of the study which exemplifies 
what can be done at the intact heart level to fully appreciate heterogeneities and complexities that 
cannot be exposed in studies with isolated myocytes. 
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4.5 CONCLUSION 
In summary, the data presented here describe an acute abnormality of myocardial Ca
2+
 handling 
caused by bradycardia, which may increase propensity to arrhythmia. A recent elegant study has 
shown the role of remodeling of Ca
2+
 handling processes for arrhythmia in chronic 
bradycardia.[160] Additional research in this complex field appears warranted. Clinically, it is 
possible that RyR2 stabilizers and NCX blockers could have a role in acute treatment of 
bradycardia-induced TdP, at least until pacing therapy can be instituted. On the cellular level, the 
mechanisms of SCR clearly merit additional investigation. 
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5.0 Ca
2+
OSCILLATIONS AND T-WAVE LABILITY PRECEDE VENTRICULAR 
ARRHYTHMIAS IN ACQUIRED LONG QT TYPE 2 
The prolongation of ventricular action potential duration (APD) and QT interval often 
leads to life-threatening polymorphic VT that show a characteristic electrocardiographic (ECG) 
appearance known as TdP. Acquired LQT syndrome (LQTS) is of critical importance because of 
its prevalence in the clinical setting. Several factors (e.g., medications, electrolyte abnormalities, 
and heart failure) impair ventricular repolarization and may lead to lethal arrhythmias. LQTS is 
also of conceptual importance because the congenital form represents a “pure global 
repolarization disease,”[161] which demonstrates a direct link between repolarization delay and 
sudden cardiac death.[162] Although the molecular defects leading to prolonged APDs in 
congenital LQTS have been elucidated in remarkable detail,[163] the mechanism by which 
impaired repolarization causes VT on the tissue level remains less clear. [14, 164, 165]Two 
hypotheses that are not mutually exclusive have been proposed. First, prolonged APDs result in 
triggered activity in the form of early afterdepolarizations (EADs).[162] Second, spatially 
heterogeneous APD prolongation leads to increased dispersion of refractoriness and may form a 
substrate for functional reentry. [163, 164]Clinically, prolonged APD is reflected on the surface 
ECG as QT interval prolongation. Several forms of temporal repolarization instability, such as 
microvolt T-wave alternans (mTWA)[166, 167] and increased QT interval variability,[168-170] 
have been linked to sudden cardiac death in clinical and experimental settings. Multiple lines of 
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evidence suggest that Cai alternans leads to APD alternans and mTWA.[27, 61, 144] However, 
arrhythmias during impaired repolarization are classically associated with bradycardia or pauses, 
whereas mTWA is usually a tachycardia-induced phenomenon. mTWA is not frequently 
observed in LQT,[171, 172] and may not be necessary for induction of LQT-related arrhythmias. 
On the other hand, nonalternans T wave lability (TWL) precedes TdP in LQTS patients[173, 
174] as well as in animal models of prolonged repolarization.[162, 175] TWL refers to beat-to-
beat changes in T-wave morphology that do not follow an alternans (i.e., ABAB…) pattern. It 
seems to be a better predictor of arrhythmia than the absolute degree of repolarization delay. 
The mechanisms underlying nonalternans repolarization lability are a matter of speculation, 
and the possible role of abnormal Ca
2+
 handling in this phenomenon remains unexplored. It is 
possible that TWL is caused by the same process that drives EADs, but generates depolarizations 
of insufficient amplitude to trigger propagating waves. 
EADs have been classically attributed to the spontaneous reactivation of the L-type Ca
2+
 
current, ICa,L, during the abnormally long APD and slow AP downstroke.[89, 176] Alternatively, 
SCR from the SR during phase 2 or phase 3 of the AP can further depolarize the plateau potential 
through the activation of the electrogenic NCX.  A similar mechanism has been documented as 
the trigger of delayed afterdepolarizations (DADs), but its role for EADs remains controversial. 
In cryoablated rabbit hearts, simultaneous mapping of transmembrane voltage (Vm) and 
cytoplasmic free Ca
2+
 in drug-induced LQT2 showed that a rapid increase in Cai precedes the rise 
of Vm at the first sites that fire EADs on the epicardium.[11] The dynamic relationship between 
Cai and Vm during an EAD supports the notion that SR Ca
2+
 overload and spontaneous SR Ca
2+
 
release activate an inward NCX current (INCX), which triggers ICa,L to produce EADs. However, 
EADs initiated by oxidative stress (with hydrogen peroxide, H2O2 0.2 to 1 mM) were attributed 
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to Ca
2+
/calmodulin kinase activation, which increased ICa,L, impaired inactivation of ICa,L and of 
voltage-gated Na
+
 current .[177]Still, SR Ca
2+
 release should not be excluded as the trigger of 
EADs because H2O2 acts at numerous targets, including the ryanodine receptor, NCX, and the 
SR Ca
2+
 pump. 
In this report, we investigated the role of Cai dynamics on TWL in a noncryoablated rabbit 
model of LQT2 using simultaneous measurements of CaiT, AP, and ECG during paced rhythms 
and focused on events that precede ventricular ectopy. 
5.1 METHODS 
5.1.1 Heart preparations 
New Zealand White rabbits (female, 60 to 120 days old) were anesthetized with 
pentobarbital (35 mg/kg intravenously) and anticoagulated with heparin (200 U/kg 
intravenously). The heart was perfused with Tyrode solution (mM): 130 NaCl, 24 NaHCO3, 1.0 
MgCl2, 4 KCl, 1.2 NaH2PO4, 50 dextrose, 1.25 CaCl2, gassed with 95% O2–5 % CO2. The AV 
node was destroyed with electrocautery to control heart rate. To minimize motion artifact, 
blebbistatin (5 to 10 μM for approximately 15 minutes) was added to the perfusate. The heart 
was immobilized in a chamber and stained with a voltage-sensitive dye (RH 237: 200 μl of 1 
mg/ml dimethyl sulfoxide [DMSO]) and loaded with a Ca
2+
 indicator (Rhod-2 AM, 200 μl of 1 
mg/ml DMSO). Epicardial bipolar pseudo-ECG was continuously monitored. Epicardial pacing 
with a unipolar electrode on the right ventricle was performed at cycle length 1.2 seconds (50 
beats/minute; bradycardia for rabbit hearts). After baseline recordings, LQT2 was modeled by 
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perfusing with Tyrode solution containing dofetilide (250 to 500 nM, Pfizer, New York, NY), a 
selective IKr blocker and lowering K
+
 and Mg
2+
 concentrations by 50 %.[178] This investigation 
conformed to the current Guide for Care and Use of Laboratory Animals published by the 
National Institutes of Health. 
5.1.2 Optical apparatus 
The optical apparatus based on 2 photodiode arrays has been described previously. The 
anterior surface of the heart was illuminated with a 520 ± 30 nm excitation beam, and the 
fluorescence was passed through a dichroic mirror (660 nm) to focus the Rhod-2 and RH 237 
fluorescence images on two 16 × 16 photodiode arrays (C4675–103, Hamamatsu Corp, 
Hamamatsu City, Japan). Outputs from the arrays were amplified, digitized at 1 kHz frequency, 
and stored in computer memory, along with surface ECG. 
5.1.3 Data analysis 
Automatic measurement of APD and CaiTD from all pixels was used to calculate APD and 
CaiTD dispersion, defined as the standard deviation of APD/CTD values. Activation time at each 
site was calculated from (dFv/dt)max of the local AP upstroke, and APD (CaiTD) at each site was 
the interval from (dFv/dt)max to the recovery of Vm to 10% of baseline (APD90 or CaiTD90). 
Isochronal maps of APD and CaiTD were generated as previously described. [179]In addition, 
custom software was created in C
++
 (Microsoft Visual Studio 6.0, Micorsoft Corp., Redmond, 
WA) for data analysis. Signals were digitally low-pass filtered (3-pole Bessel filter, 20 Hz), and 
baseline fluctuations were subtracted with a smooth cubic spline. Optical signals were evaluated 
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from 5 pixels (2-8, 8-2, 8-8, 15-8, 8-15; the numbers stand for the x-y pixel coordinates of the 16 
× 16 array). Simultaneous ECG, Vm, and Cai signals were displayed, and durations were 
measured with electronic calipers. During each scan (typically lasting 32 seconds), the interval 
from pacing stimulus to end of the T-wave (the QT interval equivalent) and the local duration of 
Vm and Cai signals were measured in 2 beats and averaged. The number of Cai peaks per AP was 
determined visually and were averaged over 2 beats from 5 pixels in each of the 32-second scans. 
Except for the dispersions of APD and CaiTD, the average value taken over these 5 pixels was 
used for subsequent analysis. 
The lability of T waves, Vm, and Cai signals was calculated as previously reported.[16] 
Briefly, the ECG , Vm, or Cai signals from each beat (unless excluded due to poor signal quality 
or subsequent PVC) were superimposed using the stimulation artifact, and the root-mean-square 
of the beat-to-beat differences in signal amplitude measured at corresponding time points of the 
repolarization segment (150 ms to 900 ms after the stimulus) were calculated. The maximal root-
mean-square value (corresponding to the most labile time point) was normalized to the amplitude 
of the signal-averaged QRS complex (defined as the maximum minus the minimum value, 
evaluated 10 to 900 ms after stimulation artifact, thus including the QRS complex). The reported 
T wave, Vm, and Cai lability values are taken as a natural logarithm of the normalized root-mean-
square values (Table 1). 
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Table 1. Summary of ECG, Vm, and Cai parameters before and after dofetilide. The asterix 
indicates that Cai lability was calculated from 2 beats preceding EAD onset, at the site of EAD 
origin. 
 
 
Parameter 
 
Baseline 
 
Dofetilide, before ectopy 
 
P 
 
APD (ms) 415 ± 118 678 ± 235 .01 
CaiTD (ms) 474 ± 144 702 ± 227 .005 
QT (ms) 481 ± 105 603 ± 172 .05 
No. of Cai peaks 1.332 ± 0.387 2.120 ± 0.469 .002 
T-wave lability -4.061 ± 0.944 -2.894 ± 0.950 .002 
AP lability -3.436 ± 0.492 -2.994 ± 0.779 .05 
Cai lability -3.338 ± 0.372 -2.970 ± 0.647 .084 
Cai lability* -4.049 ± 0.685 -3.356 ± 1.033 .05 
Vm x Cai correlation 0.9593 ± 0.0231 0.8967 ± 0.0644 .02 
 
The correlation coefficient between Vm and Cai signal values during the repolarization 
segment of the last paced beat not followed by EAD were calculated from 5 pixels as described 
earlier and averaged. Again, these values were compared to the corresponding values prior to 
dofetilide perfusion. Unless described otherwise, a 2-tailed paired Student t-test (Excel, 
Microsoft Corp.) was used to compare signal values obtained from baseline data segments with 
data segments after dofetilide perfusion, but before the onset of ventricular ectopy. P values of 
<.05 were considered statistically significant. 
 
 
 
 
 
 
 56 
5.2 RESULTS 
TdP was induced by dofetilide perfusion in all hearts (n = 8) in <10 minutes and was 
preceded by short-coupled premature ventricular beats. Premature ventricular beats on the ECG 
corresponded to EADs on optical Vm tracings. In all cases, the onset of EADs was preceded by 
prolongation of APD (415 ± 118 vs. 678 ± 235 ms; p < .01) and of CaiTD (474 ± 144 vs. 702 ± 
227 ms; p < .005) as compared with controls. The QT interval determined from epicardial ECG 
also prolonged markedly (481 ± 105 vs. 603 ± 172 ms; p < .02). Occasionally, ectopic ventricular 
beats with late coupling and Vm tracing suggestive of DADs were observed. 
5.2.1 Beat-to-beat lability of repolarization, AP, and CaT 
TWL increased in all experiments prior to the onset of arrhythmia (–4.061 ± 0.944 vs. –
2.894 ± 0.950; n = 8, p < .002). TWL corresponded to discernible changes of T-wave 
morphology during regular rhythms preceding ventricular arrhythmias (Figure 16). In contrast, 
macrovolt T-wave alternans was never observed before the onset of ventricular ectopy (n = 8). 
Similarly, the beat-to-beat lability of optical Vm signals increased prior to VT onset (–3.436 ± 
0.492 vs. –2.994 ± 0.779; p < .05). There was a trend toward an increase in CaiT lability prior to 
VT onset that did not reach statistical significance (–3.338 ± 0.372 vs. –2.970 ± 0.647; p = .084). 
However, at sites of EAD origin, CaiT lability was significantly higher compared with baseline 
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for the 2 consecutive beats preceding the onset of EADs (–4.049 ± 0.685 vs. –3.356 ± 1.033; p 
< .05). Table 1 summarizes these ECG, Vm, and Cai parameters before and after the induction of 
LQT2 but before the onset of ectopic beats. 
 
Figure 16.  Prolonged repolarization induces TWL. Examples of ECG recordings during 
pacing at 50 beats/minute A) Control. B) LQT2. T-wave morphology is constant in A, but 
changes on a beat-to-beat basis in B. ECG lability (green traces) is plotted before (C) and during 
LQT2 (D) and is superimposed on signal-averaged ECG (red traces). The Y-axis for lability is 
expanded 10-fold with respect to signal-averaged ECG. TWL is calculated as the logarithm of 
maximum ECG lability measured during the repolarization phase and normalized with respect to 
the amplitude of signal-averaged QRS. TWL is essentially absent in C and highly pronounced in 
D. Maximum lability occurs at approximately 470 ms after the pacing stimulus in this case.  
 
One might expect that if Cai lability causes Vm lability, then maximum Cai lability may 
occur slightly earlier within a cardiac cycle. However, this did not appear to be the case: the 
average timing of maximum Vm and Cai lability before onset of ectopy was 435 ± 141 and 580 ± 
95 ms after pacing spike, respectively (p=0.044 by paired t-test). The explanation seems to be 
that maximum Cai lability often occurs towards the end of the AP (late phase 3), when the 
membrane resistance is lower than during phase 2. Therefore, the effect of Cai and INCX 
variability on Vm variability may be less than during phase 2. One consistent observation is that 
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the maximum Cai lability occurs later than the second Cai peak on signal-averaged CaiT (580 ± 
95 vs. 430 ± 79 ms, p < .002). 
5.2.2 CaiT oscillations  
Aside from beat-to-beat lability, CaiT showed other forms of instability. Normal CaiTs 
were monophasic (a single Cai peak followed by a recovery to baseline) with Cai increasing 
approximately 10 ms after the rise of Vm. Occasionally, a small secondary rise in Cai appeared 
during phase 3 of the AP at a few sites. Perfusion with dofetilide increased the complexity of 
CaiT kinetics in all hearts, with the appearance of multiple Cai peaks (Figures 17 and 18). The 
average number of CaiT peaks occurring during a single AP increased significantly before the 
onset of EADs (1.332 ± 0.387 vs. 2.120 ± 0.469; P < .002). Interestingly, up to 4 distinct Cai 
peaks could be seen in some experiments, whereas the corresponding local AP remained 
monophasic, with a smooth downstroke during phase 2 and 3 (Figure 19). Cai oscillations (CaiO) 
preceded the onset of EADs in all experiments. 
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Figure 17.  CaiO precede EADs. Simultaneous recordings of Vm (blue) and Cai (red) before 
(A) and during LQT2 (B, C) A) Vm and Cai are shown at slow (top) and fast (bottom) sweep 
speeds, and both show monophasic time courses. B) Vm and Cai are shown at slow (top) and fast 
(bottom) sweep speeds. In the first 2 APs, the LQT2 condition prolonged APD and elicited Cai 
oscillations during the paced beats with no Vm instabilities. The third AP showed multiple Cai 
peaks that were occasionally coincident with EADs. C) An example of TdP onset after the fifth 
paced beat. The ECG (top trace) and the optical traces of Vm and Cai (bottom traces) were 
recorded simultaneously. The CaiO precedes the first EADs at this site.  
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Figure 18.  Time-dependent oscillations of Cai and the evolution of EADs Vm (blue) and Cai 
(red) measurements (left) during pacing (A, B) and ventricular escape rhythms (C, D). A) In 
control, Vm and Cai are monophasic and similar in shape. B) LQT2 for 3 minutes, a second 
increase of Cai appears during the AP plateau while Vm remains free of EADs. C) LQT2 for 6 
minutes promotes more complex CaiO that are associated with a single EAD. In this pixel, the 
Cai upstroke precedes the Vm upstroke. D) LQT2 for 9 minutes, 2 consecutive EADs follow each 
AP upstroke. Prominent Cai upstrokes precede EAD upstrokes.  
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Figure 19.  Spatial and temporal heterogeneity of CaiT and APs during LQT2 A) Isochronal 
map of APD90 (A (a), top left) from the anterior surface in LQT2; the field-of-view of the array is 
shown (inset d), and isochronal lines are 50 ms apart (see color scale). Cai signals recorded at 
each site are depicted in the symbolic map of the photodiode array (b). Simultaneous Vm and Cai 
from a single beat are superimposed for pixels labeled 1, 2, 3 on the maps and are shown at fast 
sweep speed (c). Marked spatial heterogeneities of CaiO appear, with the highest number of CaiO 
found at sites with the longest APDs and decrease to sites with shorter APDs. B) ECG, Vm, and 
Cai recordings from pixel (1) for 30 seconds show a gradual APD prolongation associated with 
an increasing number of CaiO and a rise of diastolic Cai. The right panel shows a shorter segment 
of the signals (green box on left) with better time resolution.  
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Figure 19A illustrates a marked spatial heterogeneity of Vm and Cai signals during 
dofetilide perfusion, but before the onset of EADs. An isochronal map of APD90 shows a marked 
APD prolongation (pixel 1) that decreased anisotropically. Before the onset of EADs, the 
correlation between Vm and Cai signals during repolarization decreased in all experiments 
(0.9593 ± 0.0231 vs. 0.8967 ± 0.0644; p < .02, 2-tailed sign test), representing an increasing 
dissociation between the oscillatory Cai signal and the monophasic shape and time course of APs. 
In paced beats immediately preceding the appearance of EADs, the spatial dispersion of CaiTD90 
exceeded the dispersion of APD90 (65 ± 29 vs. 52 ± 35 ms; p < .02). 
During a normal AP, CaiTs are tightly controlled by Vm and AP upstrokes preceded the rise 
of Cai with a delay of 10 ± 2 ms. With the appearance of premature ventricular beats, EAD 
upstrokes often coincided with a secondary CaiT peak. In 3 of 8 experiments, the first EAD 
occurred outside of the field of view of the optical maps. In 2 of 5 experiments where the first 
EAD fell in the field of view of the array, the second rise of Cai preceded the second Vm upstroke 
by 3 to 5 ms, and this temporal relationship reversed gradually as the EAD propagated away 
from its origin (Figure 20). In 3 of 8 experiments, EAD upstrokes preceded Cai upstrokes but 
with shorter Vm–Cai delays of 5 to 7 ms compared with delays during normal APs. CaiO 
preceding EAD upstrokes (Figures 17B, 18C, and 18D) were routinely observed during complex 
ectopy, such as bigeminy, trigeminy and VT runs. 
 
 
 63 
 
Figure 20.  Propagation of Vm and Cai upstrokes during an EAD A) Isochronal activation 
map of an ectopic beat (EAD) occurring during an escape rhythm. The origin of the EAD is at 
site 1. Isochronal lines are 3 ms apart. Note that another independent wavefront emanates from 
the base of the heart. B) Vm and Cai tracings from sites: 1 and 3 in (A). The first AP and CaiT are 
monophasic at site 1; during the second AP, there is a distinct second Cai peak without an EAD 
(arrow). On the third beat, an EAD appears with sufficient magnitude to propagate, as in A. C) 
The temporal relationship between Cai and Vm signals are shown at higher resolution at sites 1 to 
3 as labeled in A. At the site of EAD origin (1), Cai upstroke precedes Vm upstroke (8 ms); at site 
2, Vm is coincident with Cai; and at site 3, remote from the EAD origin, Vm precedes Cai (3 ms).  
 
As illustrated in Figure 21, a bigeminy pattern on ECG corresponded to a CaiO with an 
EAD during each beat (Figure 21A). Similarly, trigeminy corresponded to beat-to-beat 
alternations of a large CaiO with an EAD followed by a smaller Cai oscillation without an EAD 
on the next beat (Figure 21B). Non sustained runs of polymorphic VT corresponded to long CaT 
with multiple CaiO (Figure 21C). 
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Figure 21.  ECG recordings of complex ectopy: bigeminy and trigeminy correspond to 
CaiO A) ECG recording of paced rhythm with bigeminy. Each paced beat (green arrows) is 
followed by a ventricular ectopic beat (red arrow). T-waves on ECG signals are indicated by 
black arrows. Note that neither Vm nor Cai recover to baseline before the ectopic beat; in this 
sense, the paced/ectopic beat can be understood as a single complex AP. B) An episode of 
trigeminy from the same experiment. Two paced beats are followed by an ectopic beat. The 
optical tracings indicate that alternans between a short monophasic paced AP and a bigeminal AP 
underlies the trigeminal pattern. C) Simultaneous ECG and Cai tracing with brief runs of 
polymorphic VT. Pacing rate was 50 beats/min with 2:1 capture. Each run of polymorphic VT 
corresponds to a single CaiT with multiple secondary CaiO.  
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5.2.3 TdP is suppressed by interventions that abolish CaiO 
To corroborate the role of spontaneous SR Ca
2+
 release in eliciting EADs and TdP, several 
interventions were tested to reduce SR Ca
2+
 load in attempts to suppress CaiO and the generation 
of TdP. As shown in Figure 22, nifedipine (5 μM) (Figure 22A) and low external Ca2+ (100 μM) 
(Figure 22B) suppressed CaiOs, EADs, and TdP (n = 4 for each intervention), although APD 
remained prolonged. Restoration of original Ca
2+
 resulted in reappearance of CaiO and TdP. In 
other experiments (n = 3), the hearts were perfused with Tyrode solution containing ryanodine 
and thapsigargin (10 μM and 200 nM, respectively) to deplete SR before perfusion with 
dofetilide. In the presence of ryanodine and thapsigargin, dofetilide prolonged APD, but CaiO 
and TdP failed to occur. 
 
 
Figure 22.  Effect of reduced SR Ca
2+
 load on CaiO and TdP TdP was induced with LQT2 
solution then nifedipine (5 μM) was added (A) or external Ca2+ was lowered (100 μM) (B) in the 
perfusate. Both interventions attenuated CaiO and terminated TdP despite continuous dofetilide 
perfusion and marked APD prolongation.  
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5.3 DISCUSSION 
The main finding of this report is that under LQT2 conditions, CaiT oscillations occur in 
ventricular myocardium during regular rhythm. They are not caused by oscillations of membrane 
potential, which they precede by minutes. When EADs do appear, they usually follow CaiT 
upstroke at the site of EAD origin. 
Although Cai oscillations under LQT conditions have been reported before, they were 
always described in the presence of EADs and often understood as a consequence of ICa,L 
reactivation with consequent calcium-induced Ca
2+
release. Because the timing of Cai and Vm 
upstrokes is often similar and their relationship may be spatially heterogeneous, this explanation 
was difficult to disprove. Here, we show that CaiT oscillations consistently occur minutes before 
the appearance of EADs, at the time when AP downstroke remains smooth and monophasic. 
Interventions that abolish CaiT oscillations also abolish TdP. These findings indicate that the 
secondary CaiT peaks are caused by instabilities of intracellular Ca
2+
 handling caused by AP 
prolongation. These instabilities in turn promote the appearance of EADs, and eventually TdP. 
5.3.1 CaT oscillations drive EADs 
The driving role of Cai oscillations in EAD generation is supported by the analysis of the 
CaiT and AP relationship at the site of EAD focus. At the origins of EADs, the rise of Cai 
preceded the EAD depolarization (n = 2 of 5). At sites remote from EAD foci, Vm preceded Cai, 
which is expected if voltage is responsible for EAD propagation. At sites of earliest EAD 
upstroke, Cai followed the EAD depolarization in 3 of 5 hearts; even then, the short Vm–Cai 
delays (<7 ms) suggested that normal voltage-driven SR Ca
2+
 release did not occur. In such cases, 
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the EAD most likely emanated from deeper in the myocardial wall and propagated to the 
epicardial surface. In cryoablated rabbit hearts in which a thin layer of epicardium survives, Cai 
elevation always preceded the EAD depolarization.[11] The cryoablation studies support the 
interpretation that when EAD depolarizations precede Cai elevation, the site of earliest EAD 
upstrokes correspond to epicardial breakthrough of a transmural depolarization wavefront. The 
higher spatial dispersion of CaiTD compared with APD dispersion just before the onset of EADs 
also supports the notion that CaiTs are not under the control of APs. 
5.3.2 Mechanisms linking CaiT oscillations to EADs 
The most likely mechanism linking secondary CaiT upstrokes to membrane depolarization 
is the NCX current, INCX, consistent with reports that NCX blockers suppress EADs and 
TdP.[180] We speculate that CaiT oscillations are driven by spontaneous Ca
2+
 release from an 
overloaded SR. In LQT2, the long AP plateau increases Ca
2+
 influx via ICa,L because the voltage-
dependent component of inactivation is incomplete and long APDs also reduce the driving force 
for Ca
2+
 efflux via NCX. These changes indirectly increase SR Ca
2+
 uptake due to the increase of 
sarcolemmal Ca
2+
 entry and the suppression of Ca
2+
 efflux mechanisms. Consistent with this 
view, nifedipine, low external Ca
2+
, and ryanodine/thapsigargin eliminated CaiT oscillations, 
EADs, and TdP. Thus, our data indicate that spontaneous Ca
2+
 release from an overloaded SR 
network is the primary cause of ventricular arrhythmias in LQT2. 
In dofetilide-induced LQT2, CaiO always appeared before EADs and TdP. Although all 
CaiO are expected to elicit INCX oscillations, not all CaiO produced EADs because the ability of 
INCX (due to a CaiO) to sufficiently depolarize the cell membrane and produce an EAD depends 
on several factors: (1) the magnitude of the Cai elevation, which determines the magnitude of 
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INCX; [140] Vm during the plateau phase, a determinant of the magnitude of repolarizing K
+
 
currents: IK1, residual IKr, and IKs; (3) the time point along phase 2 of the AP when INCX rises, a 
determinant of the number of L-type Ca
2+
 channels that have recovered from inactivation and 
can be reactivated; and (4) the activation of the opposing repolarizing K
+
 currents (IKr and IKs) 
are also time dependent. The data provide compelling evidence that INCX is the most reasonable 
mechanism for the generation of EADs through L-type Ca
2+
 channels reactivation, but it cannot 
entirely exclude a contribution from spontaneous ICa,L reactivation. 
Nonalternans TWL is caused by the lability of ventricular APs, which is preceded by CaiO 
and CaiT lability. CaiO are not fully synchronized (Figure 17), and could contribute to AP 
lability through reverse Cai–Vm coupling. In contrast to TWL, alternans of CaiT, AP, or TWA 
was never observed before the onset of ectopy. 
5.3.3 Spontaneous SR Ca
2+
 release and arrhythmias 
Abnormal Ca
2+
 handling has been implicated in arrhythmogenesis in numerous 
pathologies,[130] including digoxin toxicity[181] and catecholaminergic polymorphic 
ventricular tachycardia.[182, 183] VT is triggered by DADs in both of these conditions. DADs 
are caused by spontaneous SR Ca
2+
 release during diastole and membrane depolarization by 
INCX.[9] However, the role of spontaneous systolic Ca
2+
 release from SR in the generation of 
EADs continues to be debated.[184] CaO in the form of sparks and waves have been reported in 
a wide range of cardiac preparations, ranging from isolated myocytes to intact perfused hearts, 
and have been implicated as an arrhythmogenic mechanism.[185] In a guinea pig model of 
ischemia/reperfusion, spontaneous CaiO appeared to drive ventricular ectopy.[186] Reperfusion 
arrhythmias thus represent another clinically relevant situation involving spontaneous Ca
2+
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release from overloaded SR. The link between delayed repolarization, SR overload, CaiT 
oscillations, and TdP may help the development of diagnostic and treatment strategies in patients 
with LQTS. 
5.4 LIMITATION 
Dofetilide was used at a relatively high dose to elicit drug-induced LQT2 because lower 
doses were less reliable at eliciting TdP. Our LQT2 model shows an extreme degree of impaired 
repolarization compared to most clinical situations and its clinical relevance must be validated. 
However, it has the advantage of reproducible TdP induction during an acute study. 
5.5 CONCLUSION 
In LQT2, APD prolongation promotes CaiT oscillations, which precede the appearance of 
EADs. The data provide a mechanistic explanation for TWL and enhance our understanding of 
arrhythmogenesis in LQTS. This may lead to improved clinical management of patients with 
impaired repolarization. 
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6.0 REGIONAL HETEROGENEITY OF Ca
2+
 KINETICS PROMOTES MEMBRANE 
POTENTIAL GRADIENTS AND TRIGGERED ACTIVITY IN DRUG-INDUCED LONG 
QT TYPE 2 
Torsade de pointes (TdP) is a lethal polymorphic ventricular tachycardia associated 
with delayed repolarization as a consequence of congenital or drug-induced/acquired impairment 
of the rapid rectifying outward potassium current (IKr), known as long QT type2 (LQT2).[84-87, 
187] Enhanced spatial heterogeneity of repolarization (i.e. dispersion of repolarization (DOR)) in 
LQT2 provides a substrate leading to unidirectional conduction blocks, initiating and sustaining 
reentrant activity and has long been implicated as a driving force for arrhythmogenesis. [93, 96, 
163] The prolongation of M cell action potentials (APs) under conditions with reduced IKr has 
been proposed as the underlying mechanism responsible for enhanced transmural DOR in 
LQT2.[7] Alternatively, it has been reported that functional variations in levels of IKr that can be 
inhibited by class III anti-arrhythmic agents play a key role in the genesis of apex/base difference 
in AP repolarization in cryoablated LQT2 models.[11]  
More recently, interruption in Ca
2+
 homeostasis (i.e. imbalance between Ca
2+
 entry 
and Ca
2+
 efflux) caused by a prolonged AP has been shown to promote Ca
2+
overload in the 
sarcoplasmic reticulum (SR). [188-190] The Ca
2+
 overloaded SR, in turn, leads to abnormalities 
in Ca
2+
 handling such as spontaneous release of Ca
2+
 from the SR. [14, 191, 192] If the 
spontaneous release of Ca
2+
 from the SR occurs during the plateau phase of an AP, the non 
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voltage gated elevation in cytosolic free Ca
2+
 levels leads to voltage instability via Ca
2+
 
dependent sarcolemmal transporters. [11, 16, 81, 105]  
We recently reported that the LQT2-induced abnormality in Ca
2+
 handling was 
pronounced, spatially inhomogeneous, and tightly correlated with the distribution of AP duration 
even before the onset of TdP.[16] Although experimental and clinical studies have demonstrated 
that Ca
2+
 abnormality can be promoted and could be spatially discordant in LQT2 animal models 
or in LQT2 patients, [12, 83] the direct interplay between spatial heterogeneity of intracellular 
Ca
2+
 handling and voltage dispersion in LQT2 is not fully appreciated.  
We optically measured intracellular Ca
2+
 dynamics and membrane potential (Vm) in 
a drug-induced LQT2 rabbit model to demonstrate the impact of enhanced spatial heterogeneity 
of cytosolic Ca
2+
 handling in the augmentation of voltage dispersion, which initiates and sustains 
LQT2 related arrhythmias. 
6.1 METHODS 
6.1.1 Heart preparation 
Female New Zealand White rabbits (60 to 120 days old) were anesthetized with 
pentobarbital (35 mg/kg intravenously) and anticoagulated with heparin (200 U/kg 
intravenously). The heart was excised and perfused on a Langendorff apparatus with Tyrode 
solution (mM/L): 130 NaCl, 24 NaHCO3, 1.0 MgCl2, 4 KCl, 1.2 NaH2PO4, 50 dextrose, 1.25 
CaCl2, gassed with 95% O2–5 % CO2. The solution temperature was adjusted to 37ºC with a 
heater. The atrioventricular node was ablated with electrocautery to control heart rate. 
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Blebbistatin (Sigma-Aldrich, St.Louis, MO; 5 to 10 μM/L for approximately 15 minutes) was 
added to the perfusate to minimize motion artifact. The heart was immobilized in a chamber and 
stained with a voltage-sensitive dye (PGH1: 200 μL of 1 mg/mL dimethyl sulfoxide [DMSO] 
solution) and loaded with a Ca
2+
 indicator (Rhod-2 AM, AnaSpec, Fremont, CA; 200 μL of 1 
mg/mL DMSO solution). Epicardial bipolar pseudo-ECG was continuously monitored. 
Epicardial pacing with a unipolar electrode from the lateral left ventricle was performed at cycle 
length 1.2 s (50 beats/minute; profound bradycardia for a rabbit heart). After baseline recordings, 
LQT2 was induced by perfusing the heart with Tyrode‟s solution containing Dofetilide (500 
nM/L, Pfizer, New York, NY) and lowering K
+
 and Mg
2+
 concentrations by 50%.[178] This 
investigation conformed to the current Guide for Care and Use of Laboratory Animals published 
by the National Institutes of Health. 
6.1.2 Optical apparatus 
The optical apparatus, which is based on two high spatiotemporal resolution CMOS 
cameras (Ultima Scimedia, Costa Mesa, CA; 100 x 100 pixels, 500-1,000 frames per second), 
has been used for simultaneous measurement of intracellular Ca
2+
 transients and membrane 
potential changes. The anterior surface of the heart with a 1.4 cm x 1.4 cm field of view (140 µm 
x 140 µm pixel resolutions) was illuminated with a 520 ± 30 nm excitation beam generated by a 
tungsten lamp with an interference filter. The fluorescence beam was divided by a dichroic 
mirror (660 nm) to focus the Rhod-2 and PGH1 fluorescence signals on two CMOS cameras. 
The digitized optical signals were saved on computer HD for off-line analysis. 
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6.1.3 Data analysis 
Optical traces of membrane potential (Vm) and intracellular Ca
2+
  transient (CaiT) at each 
pixel were normalized and digitally low-pass filtered (60 Hz cutoff, Butterworth). Activation 
time at each site was calculated from (dFv/dt)max of the local Vm or CaiT upstroke, and action 
potential (AP) duration (APD) and CaiT duration (CaiTD) at each pixel was the interval from 
(dFv/dt)max to the recovery of Vm [2] to 20% of baseline (APD80 or CaiTD80). APD80/CaiTD80 
and APD/CaiTD dispersion was always calculated during paced rhythm, in the absence of 
triggered activity. Automatic measurement of APD80 and CaTD80 from all pixels (100 x 100 
pixels) was used to calculate APD80 and CaiTD80 dispersion, defined as the standard deviation of 
APD80 (or CaiTD80) values. Amplitudes of secondary Ca
2+
 elevation at each pixel were 
approximated by calculating „area under curve‟ [137] of normalized CaiT over time-interval 
from beginning of first secondary Ca
2+
 release (SCR) to end of CaiT per AP.  A maximal 
recovery slope (MRS) of normalized CaiT at each pixel was calculated from negative maximum 
value in the first derivative of CaiT before the onset of SCRs. A modified phase angle analysis 
was performed to calculate phase angles of Cai and Vm kinetics per AP. Briefly, after local 
maxima and local minima were defined at a given pixel, individual segments between 
neighboring local minima and maxima were normalized between 0 to π (rising phase) or –π to 0 
(falling phase). Earliest rising times of SCRs and Vm re-depolarization at each pixel were 
calculated from first zero phase angles. Numbers of phase singularities in CaiT per AP at each 
pixel were calculated by counting a total numbers of local maxima and minima per AP. The 
amplitude of the Vm gradient vector is defined as  
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 The gradients were calculated from discrete data (100x 100 pixels) and we used 
spatial step of 3 pixel sizes to approximate the partial derivatives in the formula above. Spatial 
heterogeneity (SH) was calculated as natural logarithm of standard deviation of Vm (or Cai) 
signal amplitude in each 100 x100 pixels, averaged over repolarization time-interval (taken from 
100 ms after action potential upstroke to APD80).  Data analysis and creation of map images and 
video clips was performed with software created by the first author in MatLab. Statistical 
comparison between SH of Cai and Vm was performed with paired t-test.  
6.2 RESULTS 
6.2.1 Increase in spatiotemporal heterogeneity of intracellular Ca
2+
 handling in long QT 
type 2 
At a baseline heart rate of 1.2 s cycle length (CL), moderate bradycardia dependent SCRs, 
which were fully reversible at 500ms CL, occurred during the plateau phase of the AP. After 
induction of LQT2 but before the onset of triggered activity, the episodes of SCRs per AP, 
defined with numbers of local minima and maxima, were more pronounced compared to those at 
baseline (p<0.01, n=5) (Figure 23A). Intriguingly, dynamic alternations in the spatial distribution 
of cytosolic Ca
2+
 levels (or spatial heterogeneity of amplitudes in CaiT) were consistently 
observed in LQT2 as a result of enhanced spatial heterogeneity of Cai handling (i.e. kinetics of 
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Ca
2+
 recovery,  onset times of SCRs, and frequencies of SCRs) (Figure 23B&C). Occasionally, 
sub-millimeter scale spatial heterogeneities of cytosolic Ca
2+
 levels with small „islands‟, which 
were isolated from neighboring pixels, were formed (Figure 24).  
 
Figure 23. Abnormality in Cai handling in LQT2 A) Augmentation of SCRs in LQT2. Left 
three panels show superimposed traces of CaiT and phase angles in different conditions. A heart 
was paced at 1.2s cycle length before induction of LQT2 (baseline) and during LQT2. A right 
panel shows statistical comparison of numbers of phase singularities (local maxima and minima) 
during plateau per AP between baseline and LQT2. B) Dynamics alternation of spatial 
distribution of CaiT amplitude. A left panel shows superimposed traces of CaiT in three different 
sites (a, b, and c in C). A middle panel shows variation of standard deviations of normalized Cai 
amplitude in 100 x 100 pixels with a time dependent manner. A right panel shows the statistical 
comparison of calculated spatial heterogeneity between baseline and LQT2. C) Snapshots of Cai 
amplitude maps at given times (240ms, 360ms, 480ms, 600ms, and 720ms in B). Square dots 
indicate site a, b and c in B. D) Spatial heterogeneity of Cai handling. A left panel shows a map 
of maximum recovery slopes (MRSs) of CaiTs before the onset of SCRs. A middle panel shows 
a map of onset times of SCRs. A right panel shows a map of numbers of local maxima and 
minima during plateau phases of APs. Square dots indicated site a, b, and c.  
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Regional differences in the delayed recovery of CaiT  due to the spatial heterogeneity of 
SCRs eventually led to dispersion of area under curve [137] of CaiT per AP and CaiTD (Figure 
25A). Spatial distribution of calculated AUC was correlated with the dispersion of CaiTD80 in 
LQT2 (r=0.932±0.065, n=5). The AUC distribution in LQT2 reflected one of baseline 
(r=0.88±0.054, n=5), but was more pronounced than in baseline (p<0.02, n=5) (Figure 25B).  
 
 
Figure 24. Sub-millimeter scale heterogeneity of Cai handling A) A picture of a Langendorff 
perfused heart. A black square (1.4 cm x 1.4 cm) indicates a field of view of optical mapping. B) 
Superimposed optical traces of normalized Cai in site a, b and c in C. Vertical dot lines labeled 
with 1, 2 and 3 indicate time lines of Cai mapping in C. C) Maps of normalized Cai amplitudes at 
a given time. 1, 2, and 3 indicate the corresponding time lines in B. square dots indicate site a, b, 
and c with 400 µm distances.  
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Figure 25.  Spatial heterogeneity of AUC and dispersion of CaiTD80 A) A picture of a 
Langendorff perfused heart. A black square indicates a field of view of optical mapping. a, and b 
in the square indicate site a and b in the middle panel. A middle panel shows superimposed 
optical traces of normalized Cai in site a and b in A during baseline (top) and LQT2 (bottom). A 
right panel shows a time course of variation of SD of normalized Cai amplitudes in 100x100 
pixels during baseline (top) and LQT2 (bottom). B) Spatial heterogeneity of AUC (of CaiT). Left 
two panels show spatial distribution of AUC during baseline (left) and LQT2 (right). A right 
panel shows statistical comparison of SD in AUC between baseline and LQT2. C) Spatial 
heterogeneity of CaiTD80. Left two panels show spatial distribution of CaiTD80 during baseline 
(left) and LQT2 (right). A right panel shows statistical comparison of SD in CaiTD80 between 
baseline and LQT2.  
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6.2.2 Spatiotemporal interplay between SCRs and Vm re-depolarization in LQT2 
In LQT2, the calculated spatial heterogeneity of CaiT amplitudes was more striking than 
calculated regional differences in Vm (p<0.01, n=6) (Figure 26A). The spatial organization of 
cytosolic Ca
2+
 levels was closely correlated to dispersion of Vm during the plateau phase of APs 
at a given time (Figure 26B&C). To investigate whether spatial organization of SCRs promotes 
Vm dispersion or regional differences in Vm instability elicits spatial heterogeneity of SCRs, we 
compared the rise times of SCRs with those of phase 2 EADs. Highly selective suppression of 
SCRs with RyR2 stabilizer, 1μM of K201, was also performed to further elucidate the interplay 
between SCR and Vm. SCRs during the plateau phase of APs in LQT2 always preceded phase 2 
EADs (time delay= 9.2±5.2ms, n=50,000) (Figure 26D). This time delay between SCRs and 
phase 2 EADs caused a loss in the spatial correlation between Cai and Vm because the spatial 
heterogeneity of Cai occurred before Vm dispersion (Figure 26E). Suppression of SCRs 
eliminated phase 2 EADs (Figure 26E). Furthermore, more oscillatory events were observed at 
regions with longer APD80/CaiTD80 (Figure 27 B). The delayed recovery of APs due to phase 2 
EADs corresponding to SCRs in LQT2 (r=0.9546±0.0319, n=5) promoted further prolongation 
of AP duration, and regional differences in the delayed recovery of APs resulted in augmented 
dispersion of repolarization (Figure 27B). Suppression of SCRs with K201 significantly reduced 
dispersion of repolarization in LQT2 (p<0.01. n=5).  These findings suggest that the spatial 
heterogeneity of SCRs in LQT2 is a driving force of voltage dispersion and/or DOR.  
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Figure 26. Spatiotemporal coupling between Cai and Vm A) statistical comparison between 
calculated spatial heterogeneity (SH) of Cai and Vm. B) Maps of normalized Cai and Vm 
amplitudes at a given time. Square dots indicate site a, b, and c for C. C) Spatial correlation 
between Cai and Vm amplitudes. A left panel shows superimposed optical traces of normalized 
Cai (top) and Vm (bottom). A vertical dot line indicates a timeline of Cai and Vm mapping in B. A 
right panel shows a scatter plot of Cai vs. Vm. r represents correlation coefficient between Cai and 
Vm amplitudes. D) Maps of times of SCRs/Cai oscillations (top) and EADs/Vm oscillations 
(bottom). The rise of SCR precedes the rise of EADs in all 100 x 100 pixels. E) Continuous 
spatial correlation during a single AP in LQT2 (top) and in LQT2 with 1µM of K201 perfusion 
(bottom) at the same pixel. r represents a spatial correlation coefficient between Cai and Vm. 
Higher r values show that either Cai or Vm causes the other.  
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Figure 27. Correlation between spatial heterogeneity of CaiTD80 and dispersion of APD80 
A) A picture of a Langendorff perfused heart. A black square indicates a field of view of optical 
mapping. a, and b in the square indicate site a and b in B. B) Tight linear relationship between 
dispersion of CaiTD80 and APD80. A left panel shows superimposed optical traces of normalized 
Cai and Vm in site a (top) and b (bottom) in A. A middle panel shows maps of CaiTD80 and 
APD80. A right panel shows a scatter plot of CaiTD80 vs. APD80. C) Decreases in dispersion of 
CaiTD80 and APD80 after suppression of SCRs with 1µM of K201. A left panel shows 
superimposed optical traces of normalized Cai and Vm in site a (top) and b (bottom) in A. A right 
panel shows maps of CaiTD80 and APD80. D) Statistical comparison of dispersion of APD80 (top) 
and CaiTD80 (bottom) in LQT2 before and after K201 infusion.  
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6.2.3 The impact of enhanced Vm dispersion during phase 3 of APs in the initiation of 
arrhythmogenic triggered activity 
Abnormally high Vm dispersion, which was correlated with the spatial heterogeneity of 
cytosolic Ca
2+
 levels, was observed during phase 3 of APs before the onset of triggered activity 
in LQT2 (Figure 28A). To test the role of enhanced voltage dispersion during phase 3 of APs in 
the initiation of triggered activity, Vm gradients immediately before the onset of triggered 
activity was calculated.  Intriguingly, such Vm gradients preceding the onset of triggered activity 
were spatially lined up with the origins of triggered activity (Figure 28B&C).  The triggered 
activity was more pronounced at regions with higher Vm gradients (>94 percentile) (Figure 28D). 
The triggered activity was completely suppressed by reducing Vm gradients as a result of 
suppression/prevention of SCRs with K201 in 8 out of 9 hearts (pre-perfusion of 1μM of K201 in 
4 hearts and post-perfusion of  1μM of K201 in 5 hearts) (Figure 28E). These findings suggest 
that abnormally enhanced Vm gradients during phase 3 of APs in LQT2 are Ca
2+
 dependent and 
can play a crucial role in the initiation of triggered activity.  
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Figure 28. Vm gradients and triggered activity A) An example of Vm gradients and triggered 
activity in LQT2. A left panel shows superimposed optical traces of normalized Cai (top) and Vm 
(bottom) in site a, b and c. A middle panel shows maps of normalized Cai and Vm amplitude 
10ms before the onset of triggered activity. A right panel shows a map of activation of triggered 
activity. B & C) Spatial correlations between Vm gradients and the origins of triggered activity in 
two different hearts. D) Percentile ranks of Vm gradients at the origins of triggered activities in 
six different hearts. E) Elimination of triggered activity after reduction of Vm gradients with 
K201 perfusion. A left panel shows superimposed optical traces of normalized Cai and Vm during 
LQT2 arrhythmia. A right panel shows superimposed optical traces of normalized Cai and Vm 
after suppression of LQT2 arrhythmia with K201 perfusion in the same heart. VG: Vm gradient, 
and AT: activation time. 
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6.2.4 The role of SCEs in the initiation of local early afterdepolarizations (EADs) and 
propagating delayed afterdepolarizations (DADs) 
Previously, we reported that secondary Ca
2+
 oscillations, which precede Vm instability, 
are capable of eliciting reactivation of the L-type calcium channel via Na-Ca exchangers leading 
to triggered activity such as EADs and DADs.[16] We further investigated the direct interplay 
between SCRs and triggered activity without mediation of Vm gradients. In addition to triggered 
activity along the Vm gradients, numerous EADs and DADs were observed in this LQT2 models 
(Figure 29A). At the origination points of EADs and DADs (or the earliest sites of occurrence), a 
rise of Cai always preceded the rise of Vm re-depolarizations.  The majority of early phase EADs 
were localized without propagation and were spatially discordant. Occasionally, local 
propagation of EADs occurred and was driven by voltage (Figure 29B).  On the other hand, once 
DADs were initiated with consistently preceding SCRs to Vm re-depolarization during phase 4 of 
APs, global propagation of DADs was persistent and driven by voltage (CaiTs follow APs) 
(Figure 29C). These observations are consistent with our previous studies. 
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Figure 29. EADs and DADs in LQT2 A) Superimposed optical traces of normalized Cai and 
Vm during LQT2 arrhythmia. Green arrows indicate a diastolic elevation of Cai and Vm. Black 
arrows labeled with 1, 2, and 3 indicate DADs. Red arrows labeled with a, b, and c indicate 
EADs occurring immediate after DADs. B) Zero phase maps of Cai (left) and Vm (right) during 
DADs indicated in A. At the origins of DADs, rising of CaiT precedes rising of Vm. In the 
regions of DAD propagation, rising of Vm precedes to rising of Cai. C) Zero phase maps of Cai 
and Vm during EADs indicated in A. Most of early phase EADs were localized without 
propagation, but once propagation of EADs occurred, rising of Vm precedes rising of Cai.  
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6.3 DISCUSSION 
LQT2 is known to increase the spatial heterogeneity of AP repolarization (i.e. dispersion 
of repolarization (DOR)) and has been widely implicated as an arrhythmogenic factor. However, 
mechanisms fundamental to LQT2 related augmentation of DOR and its impact of 
arrhythmogenesis remain unclear. Here, we report for the first time that spatially discordant 
abnormality in Cai handling promotes Vm gradients, which is responsible for triggered activity in 
LQT2. This Ca
2+
 dependent dispersion of repolarization offers an alternative to the M-cell 
hypothesis to explain increase in repolarization gradient in LQT2. Consideration of the 
mechanisms of these interesting findings requires further discussion.  
6.3.1 Transmural DOR vs. epicardial DOR 
Because IKs current density in midmyocardial cells (M cells) is relatively weak, M cells 
are more sensitive to many APD-prolonging conditions than epicardial and endocardial 
cells.[193] The preferential AP prolongation of M-cells has been linked to underlying 
mechanisms of markedly enhanced „transmural‟ DOR in LQT2.[7, 97] Conversely, experimental 
studies have shown that heterogeneous AP prolongation occurs along the surface of a heart in 
various species in LQT2.[11, 93, 96, 194] It is controversial whether or not electrotonic influence 
of subepicardial M-cells contributes to the large epicardial dispersion of repolarization (Base  
Apex). However, it is unlikely that M-cells promote epicardial DOR since 1) M cells reside 
throughout the deep subepicardial layers without any base-apex preference[98, 195] and 2) 
cryoablation of septum and conduction system except for a 1 mm thick layer of epicardium  
shows marked base to apex gradients of repolarization in LQT2. Thus, other factors rather than 
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M-cells may account for epicardial repolarization gradients.[11, 196] Alternatively, it has been 
proposed that there is a functional difference in the level of IKr along the epicardium that can be 
blocked by class III antiarrhythmic drugs.[11] However, experimental evidence supporting this 
hypothesis is lacking.  
6.3.2 Possible effects of Ca
2+
 abnormality on AP prolongation 
Intriguingly, AP prolongation in LQT2 is often associated with oscillatory events and 
modulated with agents which increase ICa,L.[7] The role of Cai handling in further AP 
prolongation in LQT2 is not fully demonstrated, but it is possible that cytosolic Ca
2+
 elevation 
during AP plateau due to spontaneous SR Ca
2+
 release could produce membrane potential 
instability (i.e. EADs) and eventually result in further repolarization delay in LQT2. Previously, 
we reported that oscillations in CaiT occurred on the surface of the heart in a rabbit LQT2 model 
before the onset of TdP and were correlated with further AP prolongation.[16, 197] It is not 
surprising that spontaneous elevation (oscillation) in Cai level, which is not voltage gated, delays 
AP repolarization as a consequence of positive Cai-Vm coupling via Ca
2+
 dependent sarcolemmal 
transporters namely as NCX, but the interplay between Cai handling and AP prolongation in 
LQT2 has not been fully understood. 
6.3.3 Markedly enhanced Ca
2+
 heterogeneity in LQT2 
Ca
2+
 homeostasis (i.e. balance between transmembrane Ca
2+
 influx and Ca
2+
 efflux) in 
cardiac myocytes is tightly modulated by membrane potential and by the Ca
2+
 uptake and release 
controlled by proteins on the SR. Experimental studies have shown that these processes are 
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altered in numerous pathologies and result in changes in systolic and diastolic Ca
2+
.[70, 71, 78, 
80, 198] Specifically, conditions with delayed repolarization alter the amount of Cai uptake in 
the lumen of the SR by SERCA during each cardiac cycle due to the delayed voltage dependent 
inactivation of L-type Ca
2+
 channels (increase in Ca
2+ 
influx) and the reduced NCX driving force 
(decrease in Ca
2+
 efflux). Thus, beat to beat basis imbalance between Ca
2+
 entry and Ca
2+
 efflux 
results in gradual SR Ca
2+
 overload leading to spontaneous SR Ca
2+
 release. The next question is 
whether or not this phenomenon can be spatially heterogeneous. Experimental results have 
suggested that intercellular Ca
2+
 diffusion through gap junctions may facilitate synchronous 
spontaneous Ca
2+
 releases in neighboring cells.[197, 199] On the other hand, it was reported that 
spontaneous SR Ca
2+
 release can be persistent and even more pronounced when gap junctions 
are inhibited.[143] This observation suggests that intracellular oscillatory events in a single cell 
can result from its own intrinsic properties rather than intercellular synchronization.  
Here, after induction of LQT2, the spatial and temporal complexity of cytosolic Ca
2+
 
levels was significantly enhanced as a consequence of spatiotemporal changes in Cai kinetics. 
This is consistent with clinical observations showing that the relaxation of cardiac contraction in 
LQT2 patients was spatially inhomogeneous.[83] The underlying mechanisms of mechanical 
dispersion in LQT2 and its influence to voltage dispersion remain elusive. It is possible that this 
spatial heterogeneity of Cai handling in LQT2 reflect repolarization gradients. However, since 
Ca
2+
 uptake in SR by SERCA and spontaneous Ca
2+
 release are not fully voltage dependent, 
regional variations in intrinsic properties of Cai dynamics are likely to cause the Ca
2+
 
heterogeneity. Experimental studies have shown that in mammalian hearts, Cai handling 
molecules such as Cav1.2α, NCX1, and SERCA2a are differentially expressed across the 
ventricular wall as well as along the epicardial surface and this regional difference is pronounced 
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more in female than in male.[12, 20, 21, 200] As a result, intrinsic inhomogeneous distribution of 
Ca
2+
 handling molecules could explain markedly enhanced Ca
2+
 heterogeneity in LQT2.  
6.3.4 Spatial similarity of Ca
2+
 abnormality between bradycardia and LQT2  
In a previous chapter, it was shown that bradycardia alone elicits spontaneous Ca
2+
 
releases, which are spatially inhomogeneous and tightly correlated with the regional expression 
of Ca
2+
 handling molecules. The similarity in spatial distribution of Cai handling between 
bradycardia baseline and bradycardia-LQT2 (Figure 25B) illustrates that complex spatial patterns 
of Cai handling in LQT2 may reflect intrinsic heterogeneity of Cai handling, which was already 
accentuated in bradycardia alone. Even if this conjecture is accepted, it is unclear why the 
submillimeter-scale spatial heterogeneity of Cai should only appear after LQT2 induction. In 
addition to complex heterogeneity in Cai dynamics, Cai signaling mechanisms are likely to be 
activated and to complicate the system through positive and negative feedback processes. 
Additional experiments are required to fully elucidate the answer to this problem. 
6.3.5 Correlation of Ca
2+
 and Vm gradients  
In numerous pathologies, spatially discordant alternations in cytosolic Ca
2+
 handling are 
responsible for the dispersion of Vm instability/alternans, presumably due to positive Cai-Vm 
coupling via electrogenic Ca
2+
 dependent Na-Ca exchangers.[10, 26, 102] The most striking 
observation in this report is that spatiotemporal alternations in Cai handling in LQT2 were tightly 
correlated with dynamic changes in Vm dispersion. The notions 1) that SCRs, whose regional 
variation is responsible for the spatial heterogeneity of Cai, always precede early phase 
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membrane re-depolarization, 2) that spatial heterogeneity of Cai and CaiTD are consistently 
bigger than spatial heterogeneity of Vm and APD respectively, and 3) that perfusion with 1µM 
K201, which acts exclusively on ryanodine receptors and specifically affects Cai handling,[151] 
abolished the spatial heterogeneity shows that the regional variation of Cai handling can promote 
voltage dispersion.   
6.3.6 Vm gradients initiate triggered activity 
Repolarization gradients in LQT2 have been shown to initiate unidirectional conduction 
blocks and have been separated from that of spontaneous SR Ca
2+
 release which initiates 
triggered activity such as early afterdepolarizations (EADs) and delayed afterdepolarizations 
(DADs).  In this model, triggered activity was initiated in the steepest region of voltage gradients 
(3.12±0.64 mV/mm
2
, n=6). A voltage gradient along the direction of propagation of electrical 
activity is normal and facilitates synchronized contraction throughout the heart. However, in 
experimental studies, steep voltage gradients in pathologies can generate arrhythmogenic 
triggered activity.[116, 201] For example, in myocardial infarct models, a voltage gradient across 
the ischemic border zone can lead to a diastolic injury current at the normal side of the ischemic 
border. Such small injury currents can slightly depolarize the normal tissue and facilitate the 
occurrence of triggered activity. [116] Although it is well established that gradients of diastolic 
Ca
2+
 levels promote repolarization gradients in numerous pathologies,[20, 22, 26, 102] the direct 
interplay between Ca
2+
 dependent voltage gradients and triggered activity has not been 
established.  
Here, we observed that LQT2 mediated triggered activity is also initiated by Vm gradients 
during phase 3 of APs. Despite high spatial correlation between origins of triggered activity and 
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voltage gradients in this study, further investigation of clear mechanistic explanation on the 
impact of Ca
2+
 mediated voltage gradients in the initiation of triggered activity is required. 
Theoretically, regional differences in cytosolic Ca
2+
 levels can generate voltage dispersion via 
electrogenic NCX during the plateau phases of APs. If electrotonic currents from „donor‟ cells 
are sufficient to partially depolarize „recipient‟ cells, triggered reactivation of L-type channels 
can initiate triggered activity.  
In cryoablated rabbit LQT2 models, Maruyama et al. recently reported similar 
observations. According to the report, enhanced voltage gradients during phase 3 of APs can 
promote phase 3 EADs that lead to triggered activity. Intriguingly, they argued that the late 
phase voltage dispersion in acquired LQT syndrome was independent of regional variations in 
Ca
2+
 handling because the phase 3 EADs were not suppressed with BAPTA infusion.[196] 
However, the efficacy of BAPTA in chelating Ca
2+
 in intact animal models is controversial.[10] 
In contrast, we observed here that highly specific inhibition of secondary Ca
2+
 release with 1µM 
of K201, a dose at which it selectively decreases the RyR2 open probability, consistently 
eliminated triggered activity. Previous interventions into cytosolic Ca
2+
 handling with partial 
inhibition of L-type Ca
2+
 channels with nifedipine or by reducing [Ca
2+
]o suppressed triggered 
activity.[16] Such experimental evidence supports that triggered activity is Ca
2
 -dependent.  
Since we tested the role of voltage gradients in the initiation of triggered activity on the 
surface of hearts, further investigation is required to elucidate whether a steep voltage gradient 
on the surface of hearts account for the triggered activity or the triggered activity is initiated in 
deeper regions and propagates to the surface along the voltage gradient. However, experimental 
evidence has shown that triggered activity was observed in cryoablated rabbit hearts under 
similar LQT2 conditions,[11, 196] which suggests that TA may not originate intramurally. In the 
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canine wedge model of LQT2, breakthrough sites of triggered activity occurred consistently 
along the epicardial voltage gradient and not deep inside the ventricular walls.[202] If the 
triggered activity originates intramurally independent of voltage gradient, the breakthrough 
pattern of TA could not follow epicardial voltage gradient but rather propagates to earlier 
recovery areas.  
6.3.7 Non voltage-gradient mediated triggered activity such as EADs and DADs in LQT2 
In a way, the observed requirement for steep Vm gradient in triggering propagated 
EADs is not surprising: secondary Cai oscillations occurring during the AP plateau in the 
absence of local Vm gradient would be expected to cause a “local” EAD, but no propagation 
because the EADs may not be sufficient to initiate propagating triggered activity – this is a 
phenomenon we have repeatedly observed (Figure 7). On the other hand, Cai oscillations that 
occur even in the absence of a local Vm gradient in excitable tissue can certainly cause 
propagating ectopic beats, also known as DADs, which has been consistently observed by our 
group and others (Figure 29).[11, 16, 196, 203]  
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6.4 LIMITATIONS 
Optical recordings of membrane potential and Ca
2+
 dynamics on the anterior surface of 
rabbit hearts revealed a complex spatial heterogeneity of Cai handling which was responsible for 
voltage dispersion leading to triggered activity in LQT2. The 2D nature of optical mapping does 
not provide LQT2 related enhancement of transmural differences in Cai handling and its link to 
triggered activity which originates from deeper layers of the ventricles. In addition, positive 
coupling of Cai-Vm via INCX most likely accounted for Cai dependent Vm dispersion in LQT2, but 
due to the lack of a reliable NCX inhibitor, further assessment of the NCX mediated interplay 
between Cai heterogeneity and Vm dispersion was not fully investigated.  
6.5 CONCLUSION 
 
In summary, we report that a marked increase of CaiT heterogeneity develops under 
LQT2 conditions, with the formation of unexpectedly small, irregularly shaped regions of 
elevated Cai. We propose that the increase in CaiT heterogeneity contributes to augmentation of 
Vm gradients and DOR and is highly arrhythmogenic by generating triggered activity or by 
initiating reentrant circuits. The suppression of TdP by a RyR2 selective K201 concentration 
underscores the importance of a detailed understanding of arrhythmogenic mechanisms for the 
development of rational treatment strategies.  
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APPENDIX A 
INTRACELLULAR Ca
2+
 OSCILLATIONS AND T-WAVE LABILITY (TWL) 
PRECEDE TORSADE DE POINTES (TDP) IN A RABBIT MODEL OF LONG QT TYPE 
2 (LQT2) 
 
 
 
 
Authors: Jan Nemec, Jong Kim, Bethanny Gabris, Guy Salama, University of Pittsburgh, 
Pittsburgh, PA ; J. Am. Coll.Cardiol.2010;55;A2.E16 doi:10.1016/S0735-1097(10)60017-4  
Background: Action potential (AP) prolongation results in TdP in clinical and experimental 
LQT2, but the exact mechanism remains uncertain. T-Wave alternans has been proposed as a 
marker of arrhythmic risk and is elicited by APD and Ca
2+
 alternans. However, non-alternans 
TWL hasbeen associated with TdP in LQT syndrome. We hypothesized that TWL at constant 
heart rate precedes TdP in a LQT2 model and that it is caused by abnormal Cai dynamics. 
Methods: Female rabbit hearts were perfused, AV node was ablated and ventricles paced at 50 
beats per minute. Epicardial ECG was recorded during optical mapping (RH 237 and Rhod-2 
AM) of AP and Cai. LQT2 was mimicked by Dofetilide (D; 500 nM/L) and decrease in [K
+
]o 
and [Mg
2+
]o. TWL was calculated as logarithm of root-mean-square of differences between T 
wave amplitude from subsequent beats. 
Results: D prolonged AP durations and induced TdP (n=8/8). Baseline Ca transient (CaT) was 
usually monophasic. Occasionally, a small secondary peak was observed. The number of CaT 
peaks per AP during paced rhythm increased upon D addition and prior to VT onset compared to 
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baseline in all cases (Number of CaT per AP: 1.33±0.39 vs 2.32±0.47, p<0.002). This was 
accompanied by increased TWL (-4.06±0.94 vs -2.89±0.95, p<0.002). 
Conclusions: TWL precedes TdP in rabbit LQT2 model. Complex Ca dynamics (>1 CaT peak 
per AP) occurs during prolonged AP, promoting TWL and TdP. Possible mechanisms include 
secondary Ca2+ release from an overloaded sarcoplasmic reticulum and enhanced Na/Ca 
exchange current. 
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APPENDIX B 
ACQUIRED LQT2 LEADS TO MARKED SPATIAL HETEROGENEITY (SH) OF Ca
2+
 
TRANSIENT 
 
 
 
 
Authors: Jong J. Kim, Jan Nemec, Guy Salama, University of Pittsburgh, Pittsburgh, PA; J. Am. 
Coll. Cardiol. doi:10.1016/S0735-1097(11)60003-X 2011;57;E3.  
Background: Enhanced dispersion of repolarization (DOR) in LQT2 and abnormalities of 
intracellular Ca2+ [2] have been proposed as arrhythmogenic mechanism of Torsade de Pointes 
(TdP). However, the interplay and relative roles of DOR and SH of Cai is not understood. 
Methods: Simultaneous optical maps of membrane voltage (Vm) and Cai were recorded from 
the anterior surface of Langendorff rabbit hearts (n=7) paced at 50 bpm after AV node ablation. 
After perfusion with normal Tyrode (baseline; B), LQT2 was induced by adding dofetilide (0.5 
μM) and reducing K+ (2 mM). Standard deviation of Vm and Cai signal amplitude was 
calculated in each 100x100 pixel frame and averaged over repolarization time-interval (from 100 
ms after action potential upstroke to APD80). SH was calculated from paced beats as natural 
logarithm of this average at B and during LQT2. 
Results: Irregular regions of elevated Cai (~2x3 mm) appeared during phase 2 and 3 of action 
potential. During LQT2, SH of Cai exceeded SH of Vm in all hearts (-3.28±0.45 vs -3.55±0.41; 
p<0.01), although high Cai correlated with high Vm. At B, SH of Vm and Cai were similar and 
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significantly lower than during LQT2. 
Conclusions: SH of Cai transient during LQT2 exceeds SH of Vm. Regions of elevated Cai 
exhibit complex oscillations on a mm scale. SH of Cai may reflect intrinsic regional differences 
of Cai handling mechanisms accentuated by repolarizationdelay of LQT2 rather than follow SH 
of Vm. Instead, SH of Cai appears to enhance SH of Vm, elevate DOR and facilitate TdP. 
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APPENDIX C 
BRADYCARDIA ELICITS A SECONDARY Cai ELEVATION DURING THE 
ACTION POTENTIAL (AP) PLATEAU WHICH IS SPATIALLY HETEROGENEOUS, 
PROLONGS AP DURATIONS (APD) FURTHER, ENHANCES DISPERSION OF 
REPOLARIZATION (DOR) AND MAY EXPLAIN THE ARRHYTHMOGENIC 
PROPERTIES OF BRADYCARDIA 
 
 
 
 
Authors: Jong J. Kim, Jan Nemec, Rita Papp, and Guy Salama, University of Pittsburgh, 
Pittsburgh, PA; AHA 2011 Scientific Session APS.403.03a 
Introduction: Bradycardia is known to prolong APD and DOR and is a factor that promotes 
arrhythmia in long QT type 2. In numerous conditions, spontaneous Ca
2+
 release from 
sarcoplasmic reticulum has been shown to trigger early afterdepolarizations, ectopic activity that 
initiate arrhythmias, but the interplay between secondary Ca
2+
 elevation (SCE) and membrane 
excitability has not been demonstrated in bradycardia.  
Objectives: To correlate voltage-depolarization during the AP plateau to SCE during 
bradycardia. 
Methods: Dual optical mapping of intracellular calcium transient (CaT) and AP was performed 
in Langendorff perfused rabbit hearts. After AV node ablation, CaT and AP dynamics were 
investigated at physiological (120 beats per minute (bpm)) and slow heart rate (50 bpm).   
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Results: Upon changing HR from 120 to 50 bpm, APD gradually increased with a time-constant 
of 53.8±8.9 s, consistent with clinical QT measurements. The shift from 120 to 50 bpm elicited 
SCE during the AP plateau that was a) regionally heterogeneous, b) associated with enhanced 
depolarization of the AP plateau and was reversed by pacing at 120 bpm. Regional differences of 
SCE at 50 bpm were significantly increased (P<0.01, n=7) and were correlated with dispersion 
of APD (r=0.9277±0.03, n=7). SCE and APD prolongation were more pronounced at the base of 
right ventricles than the apex of left ventricles (P<0.01, n=7). Suppression of SCE with K201 (1 
µM/L) (to stabilize RyR2) reduced APD (P<0.01, n=5) and DOR (P<0.02, n=5). The molecular 
basis of the spatial distribution of SCE is currently being correlated to the intrinsic distributions 
of Ca
2+
 handling channels and transporters (Cav1.2α, RyR2, NCX and SERCA2a). 
Conclusion: These data show for the first time that bradycardia elicits SCE which contributes to 
AP prolongation and its spatial heterogeneity increases DOR. These changes explain why 
bradycardia is a critical factor to trigger Torsade de Pointes in LQT2. 
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APPENDIX D 
THE ROLE OF SPATIAL HETEROGENEITIES OF INTRACELLULAR Ca
2+
 
OSCILLATIONS (CaiO) IN LONG QT TYPE 2 (LQT2)-RELATED ARRHYTHMIAS 
 
 
 
 
Authors: Jong J. Kim, Jan Nemec, and Guy Salama, University of Pittsburgh, Pittsburgh, PA; 
Heart Rhythm, Vol 8, No. 5, PO6-113, May Supplement 2011  
Introduction: Spontaneous Ca
2+
 release from internal stores, CaiO and dispersion of 
refractoriness (DOR) have been implicated as underlying mechanisms of Torsade de Pointes 
(TdP) in LQT2. DOR remains a fundamental arrhythmogenic mechanism because it generates 
conduction blocks and the steep voltage (Vm) gradients that sustain reentry. Enhanced DOR is 
partly due to intrinsic heterogeneities of ionic currents but may also depend on spatial and 
dynamic heterogeneities of CaiO. 
Methods: Simultaneous optical maps of membrane voltage (Vm) and Cai were recorded from 
the anterior surface of Langendorff rabbit hearts (n=7) paced at 50 bpm after AV node ablation. 
After perfusion with normal Tyrode‟s, LQT2 was induced with dofetilide (0.5 µM) and low K+ 
(2 mM) and Mg
2+
 (0.5mM). Time delays between CaiO and Vm was quantitatively analyzed 
using phase maps. Spatial correlation between CaiO amplitudes and DOR/Vm dispersion in 
LQT2 but before the onset of triggered activity (TA) was investigated. Cai and Vm 
heterogeneities were mapped and correlated to the origins of TA. 
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Results: Spontaneous CaiO preceded phase 2 and 3 depolarization by 9.1503±5.1874ms. Local 
CTD80 was dependent on the amplitude of CaiO and was spatially correlated to APD80 (COE = 
0.9546±0.0319, n=5). The spatial heterogeneity of preceding CaiO was correlated to Vm 
dispersion (COE=0.8172±0.093, n=5). TA occurred primarily at the boundaries of high and low 
Vm. 
Conclusions: Spatial heterogeneities of CaiO can alter local Vm dynamics resulting in enhanced 
DOR or large Vm gradient that can initiate TA and provide the substrate of local conduction 
blocks needed to sustain TdP. 
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